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Methadone Maintenance for Heroin Addicts
Tens of thousands of people dependent on heroin are only the
beginning. Because of national policies outlawing the distribution of
opiates to addicts, our "narcotics problem" now includes an elaborate
traffic in illegal drugs, furthering organized crime; an enormous out-
lay of government resources to control narcotics "abuse"; and a stag-
gering number of property offenses committed by users needing cash
to support their habit.1
Although an effective treatment for addiction has long eluded the
medical profession, a breakthrough may be near. Recent medical
investigations have shown that methadone, a synthetic addicting
opiate, is extremely useful in the rehabilitation of heroin addicts. Re-
search begun in January 1964 by Dr. Vincent Dole and Dr. Marie
Nyswander at Rockefeller University in New York indicates that
methadone, when administered appropriately, blocks the action of
heroin, eliminates the drug craving which drives many detomdfied ad-
dicts to resume heroin addiction, and produces neither euphoria nor
other distortion of behavior. Dole and Nyswander see methadone main-
tenance as a means by which to draw a patient out of the heroin addict
1. The narcotics problem in the United States has been the subject of much discussion,
frequently polemical and based on little data. The "experts" arc in sharp disagreement
over most of the fundamental issues, including the nature and causes of addiction, the
number of addicts presently in the United States, the relationship between addiction and
crime, the effectiveness of law enforcement efforts, and the wisdom of the basic national
policy. See, e.g., H. ANSLINGER & IV. TOMPKINS, THE TRAFFIC IN NA cOTICs (1953); 1. Cna E,.
D. GmARD, R. LXE & E. ROSENFELD, THE Ro. To H (1964) [hereinafter cited as CEINw]; W.
ELDRIDGE, NARCoTICs AND THE LAw (1962); A. LINDESMITH, THE ADDICT AND THE LAW
(1965); TASK FORCE ON NARcoIcS AND DRUG ABUSE, THE PREStDENT'S ComMjIssIoN ON LAw
ENFORCEMENT AND A S1NIFTRATION OF JUSTICE, TASK FORCE REPORT. NARCoTIcs AND DRUG
ABUSE (1967) [hereinafter cited as TAsK FORCE RE.POlr]; THE PRESIDENT'S COssISSIO.N o
LAw ENFORCEmENT AND AImINLrATION OF JUSTICE, ThE CHALLENGE OF CRIME IN A FRE
SocaErY 302-03 (1967) (4 Commission members dissenting on portion of the report con-
cerning narcotics and drug abuse); Hearings on Crime in the National Capital Before the
Senate Committee on the District of Columbia, 91st Cong., 1st Sess., pts. 2 & 2A (Drug
Abuse in the Washington Area) (1969) [hereinafter cited as Hearings]; Hearings on Or-
ganized Crime and Illicit Traffic in Narcotics Before the Permanent Subcommittee on In.
vestigations of the Senate Government Operations Committee, 88th Cong., 1st & 2d Sess..
pt. 3 (1964). See also H. PACKER, THE LIITns OF THE CRIMINAL SANCrIoN 332.37 (1963);
J. SKoLNcK, JusTcE wrrioUT TRIAL (1966); notes 11, 34-35 infra.
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community, away from a life of crime, and into a productive social
role.
2
But for a variety of reasons, elements in both the medical and legal
communities oppose methadone's use in a maintenance treatment pro-
gram for addicts. What follows is a review and critical examination of
both the medical and legal controversy surrounding methadone main-
tenance.
I. The Medical Controversy
The Dole-Nyswander experimental program, currently operating
out of several New York hospitals, has essentially two phases. An ini-
tial six week in-patient period, during which the heroin addict is
withdrawn from heroin and brought to a stabilization dosage of meth-
adone, is followed by an indefinite out-patient period, during which
the patient receives regular dosages of methadone and continues to
have available a wide array of supportive services.8 As of May 1, 1969,
2. Basic accounts of the Dole-Nyswander research include: Dole & Nyswander, A Medi.cal Treatment for Diacetylmorphine (Heroin) Addiction, 193 J.A.M.A. 616 (1965); Dole,Nyswander, & Kreek, Narcotic Blockade, 118 AcRII. INTERN. MED. 304 (1966); Dole, Nys.wander & Warner, Successful Treatment of 750 Criminal Addicts, 206 I.A.M.A. 2708 (1908)[hereinafter cited as 750 Criminal Addicts], first printed in First National Conference onMethadone Treatment, Proceedings (June 21-22, 1968) [hereinafter cited as Proceedings).
Leading articles and numerous statements about the program have recently been collected
in Hearings, supra note 1.
Since 1964, methadone programs have been started by doctors in such cities as Al.buquerque, Baltimore, Boston, Chicago, New Haven, New Orleans, Philadelphia, St. Louis,and Vancouver, B.C. See Halliday & Paulus, Rehabilitation and the Narcotics Addict:
Results of a Comparative Methadone Withdrawal Program, 96 CANADIAN MED. ASS'N. J.655-69 (1967) (concerning Vancouver, B.C.); Jaffe, Zaks & Washington, Experience with
the Use of Methadone in a Multi-Modality Program for the Treatment of Narcotics Users(unpublished paper dated April 1, 1969) (concerning Chicago) [hereinafter cited as Jaffe1969]; Jaffe & Zaks, Experience with the Use of Methadone, Proceedings 23; Wieland,Methadone Maintenance Treatment of Heroin Addiction: Beginning Treatment on an
Out-patient Basis, Proceedings 31 (concerning Philadelphia).
3. During Phase I, the patient is started on oral does of methadone (dissolved in fruitjuice); the doses are increased until a stabilizing dosage of about 100 mg/day is reached.
If the medication is given in proper doses there should be no euphoria or undesirable
side effects (except mild constipation) during the stabilization period. 750 Criminal Ad-dicts, supra note 2, at 2709. Methadone has been safely used as a painkiller for years;
no toxic effects have been observed in its new use. See note 36 infra.
Phase II is the out-patient phase. Out-patients are required to return to the clinic each
day to take their supervised oral doses of methadone. The patients give daily urine samplesto be analyzed for traces of illicit narcotics and amphetamines. Eventually, if justified
by good conduct, patients are provided with several days' dosage at a time, and returnonce or twice a week for a urine analysis and other tests. Psychological, sodal, and voca.
tional support continues to be given.
Withdrawal from methadone is not, as of now, a part of the treatment. Withdrawalitself is easy, but indications are that once withdrawn from methadone, the patient ex-
periences a return of the narcotic hunger, and reverts to tie use of heroin. Researchers
believe that gradual withdrawal after several years of stable living might succeed, but thisprocedure has only begun to be tested and Dole and Nyswander see no necessity for It.
750 Criminal Addicts, supra note 2, at 2710.
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the program had admitted 1300 patients4 selected according to the
following criteria: at least four years of mainline heroin use; failure
at previous withdrawal treatment; age 20-50; no legal compulsion to
treatment; and no major medical complications such as severe alco-
holism, epilepsy, or schizophrenia.5
Follow-up statistics show that Dole's methadone maintenance pro-
gram is effective and safe for the addict population with which he is
working, and is a success from both society's and the patient's vantage
point.6 A report prepared in March 1968 by an independent "Meth-
adone Maintenance Evaluation Committee" under contract with the
New York State Narcotic Addiction Control Commission indicated
that of the 871 men admitted by that date to the several New York
hospitals housing Dole programs, 86% had continued in treatment.,
Detailed study of the two largest hospital programs showed that the
544 men continuing in treatment had made substantial progress to-
ward rehabilitation.9 None of the patients still under care had become
readdicted to heroin.10 At the time of admission only 28% of the
4. Telephone interview with Dr. Vincent Dole, June 10, 1969.
5. 750 Criminal Addicts, supra note 2, at 2709. The average patient was 33 years old,
and had been addicted 10 years. The average age of addicts on the Ne, York City Nar-
cotics Register is 28. The upper age limit in Dole's program was raLsed from 40 to 50
during the program's third year.
6. The adequacy of any treatment must be evaluated from more than one vantage
point. See Etzioni, Shortcuts to Social Change, in Tin: Pult.c IN-TEwEs, Summer 1968,
at 40-54; Katz, The Right to Treatment (draft of an article to be published in the UNt.
vmtsrry or CHicAGo LAw REvmv). Because the current approach to addiction has so many
harmful social consequences, any program that, for example, reduced addict crime could
in some sense be called useful, whether or not the patient is helped. However, methadone
maintenance not only seems successful from society's point of view, but is highly acceptable
to patients and apparently exposes them to few risks. Wieland, supra note 2, at 31-32. For
a good subjective and anecdotal account of the Dole-N)swander methadone program, in-
cluding a discussion of the patients' enthusiasm, see Hentoff, Profiles: Dr. Marie Nyswander,
41 TnE NEw Yonm, June 26, 1965, at 32, July 3, 1965, at 32.
7. Methadone Maintenance Evaluation Committee, Progress Report of Evaluation of
Methadone Maintenance Treatment Program as of March 31, 1968, 206 J.A.M.A. 2712
(1968) [hereinafter cited as Evaluation].
8. Ten per cent were considered failures and were discharged, three per cent have
dropped out, and one per cent have died. Id. at 2713. In most cases the conduct that led
to discharge involved uncooperative or anti-social behavior or non-narcotic drug abuse
(including alcoholism). Researchers felt that with these patients, for whom stopping heroin
use with blockade treatment was not enough to open the way for social rehabilitation,
methadone maintenance combined with psychotherapy and sheltered environment might
have been successful. 750 Criminal Addicts, supra note 2, at 2711. Evaluation, supra note 7,
at 2713-14.
9. Dole and Nyswander remind us that quite apart from the drug problem, their pa-
tients were "[fjurther handicapped by the ostracism of the community, slum backgrounds,
minority group status, school dropout status, prison records and anti-social companions,
[and thus] they had seemed poor prospects for social rehabilitation." Dole & NIswander.
Methadone Maintenance and Its Implications for Theories of Narcotic Addiction, in
Ass'N FOR RsmEARcH iN NEmvous AND MENTAL DisEASE, THE ADDxicTvE STATEs 360.61 (1963)
[hereinafter cited as D&N Theories].
10. Eleven per cent did, however, demonstrate repeated use of amphetamines or bari-
turates, and about five per cent had chronic alcohol problems. Evaluation, supra note 7,
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patients held jobs or attended school, but after five months in the pro-
gram 45% were either employed or in school, and after eleven months
the percentage had risen to 61%; for those remaining twenty-four
months or more, the figure was 85%. The number on welfare dropped
from 40% to 15% over the first two years, and, with the end of heroin
addiction and of a need to deal in the expensive illegal heroin market,
the number of arrests and convictions among patients decreased dra-
matically." The Evaluation Committee concluded that for those pa-
tients selected and treated as described, the program could be "con-
sidered a success."
'12
These results are all the more remarkable when compared with
those from other treatment programs.' 3 All of these established pro-
grams, which seek to induce drug abstinence, have failed to keep the
discharged patient from resuming his heroin addiction, with its asso-
at 2714. Urine analysis revealed that about fifteen per cent of the patients "use heroin
intermittently (e.g., on weekends) even though the euphoric effect was blocked." 750
Criminal Addicts, supra note 2, at 2711.
11. Prior to treatment, 91% of the patients had been in jail, and all of these had
been more or less continuously involved in criminal activity. Since coming for treatment,
88.% of the patients have had arrest-free records. The researchers estimate the reduction In
crime to be "at least 90%." 750 Criminal Addicts, supra note 2, at 2710-11. For comparison
with a matching "contrast group" selected from an ordinary Detoxification Unit In New
York, see Evaluation, supra note 7.
This data supports the belief that much addict crime is not based on any underlying
"criminal personality" but is rather a result of our national policy. By forcing the heroin
market underground and diminishing the supply of illegal drugs, that policy pushes up the
price of heroin and causes addicts to steal to maintain their habit. TAsk FORE REt ORT,
supra note 1, at 10-11. See generally Chein, Narcotics Use Among Juveniles, in NARCOTICS
ADDICrION 123 (O'Donnell & Ball eds. 1966) [hereinafter cited as O'DONNELL & BALL]; Fine-
stone, Narcotics and Criminality, in O'DONNELL & BALL 141; O'Donnell, Narcotic Addition
and Crime, 13 SOCIAL PROBLEMs 374 (1966). A conservative estimate of the amount an ad-
dict steals to finance his drug habit is $50 worth of goods per day. TAsK FORCE RE',oRT,
supra note 1, at 10. Using a much disputed but widely mentioned figure for the number
of addicts in this country-60,000-it would appear that heroin users are responsible for
stealing over a billion dollars worth of goods each year. In the Declaration of Purpose
written in 1966 for the sections of the Mental Hygiene Law concerning drug addiction,
the New York state legislature reported that "[n]arcotic addicts are estimated to be respon-
sible for one-half the crimes committed in the city of New York alone N.Y.
MENTAL HYGIENE LAW § 200 (McKinney Supp. 1968).
In evaluating Dole's figures regarding decrease in convictions, it should be recognized that
his program makes a lawyer available to patients, and that this could lead to more effective
legal representation than the patient would receive were he not affiliated with a treatment
program.
12. Evaluation, supra note 7, at 2714. The Evaluation Committee also recommended
further investigation. A discussion of this recommendation appears at pp. 1188.91 infra.
13. Comparisons among programs are difficult because these programs have often
failed to conduct sufficiently detailed evaluations, and because different programs use
different criteria of success. See Cole, Report on the Treatment of Drug Addiction, in
TASK FORCE REPORT, supra note 1, at 137-42; O'Donnell, The Relapse Rate it Narcotics Ad-
diction: A Critique of Follow-up Studies, in NARCOTICS ch. 14 (Wilner & Kassebaum eds.
1965). Any complete comparison of programs would take into account cost of the programs,
ease of implementation, and acceptability to patients.
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ciated anti-social behavior.14 The most clearly inadequate of such
programs are local "detoxification" units, which typically lack any
supportive services and involve only short-term institutionalization to
withdraw the addict. Almost without exception, these units merely
separate the addict from heroin for a brief period. The two federal
narcotics hospitals, like a number of state and local programs, offer
longer periods of care and some supportive services to improve the
likelihood of continued abstinence after discharge; but the best a
recent Presidential Commission was able to say of the federal effort
was that "there is growing evidence that [the relapse rate] is not as
high as the 94% rate found in one short-term follow-up study."'" And
even state-run civil commitment programs, despite long periods of in-
stitutionalization and sophisticated "treatment" components which go
beyond efforts to induce drug abstinence, have had only the most
limited success in keeping patients from returning to heroin once
released.' 7 Synanon, a structured community in which many of the
14. O'DONNELL & BALL, supra note 11, at 178. "[f]ost of us [doctorsi consider drug ad-
diction as a chronic relapsing illness and do not really expect long periods of abstinence.
Remarks of Dr. Samuel Slipp of N.Y. Medical College in REttAMiLrrATING TUE N'Aco.c
ADDIcT 69 (Institute of New Developments in the Rehabilitation of the Narcotic Addict,
1966). Compare the remarks of Dr. Slipp with the following from the most recent pamphlet
prepared by the Bureau of Narcotics for doctors: "It is well established that the ordinary
case of addiction yields to proper treatment, and that addicts can remain permanently
cured when drug-taking is stopped and they are otherwise physically restored to health
and strengthened in willpower.- BuREAu oF NARcoTcs, TRnE"sU Dir.., PI'AiLmEr 56:
PRESCRIBING AND DIsPENSING oF NARcoTics UNDER HARPISON NARcoTic LAW (1966) [herein-
after cited as PA_,PHL=r 56].
The poor record of other efforts at treating heroin addicts is summarized in TAmn FonczE
RPPoRT, supra note 1, at 14-17.
15. See Cole, supra note 13, at 136, 138.
16. TAsK FoRcE REPoRT, supra note 1, at 14. The frequently more sophisticated state
and local programs, for which there is virtually no data, are discussed in Cole, supra
note 13, at 138-S9, 141-43. See also Hearings, supra note 1, at 386-69, A-399-447, 30 (galleys
for Part 2A). The highly touted New York State Narcotic Addiction Control Commission
rehabilitation program was recently the subject of a leng hy expos " article in the New
York Times, where the program was described as more like a prison than a rehabilitative
effort. April 21, 1969, at 1, col. 5. Recent developments at the federal treatment hospitals
are discussed in REHABIrATING THE NAscOric ADDICT, supra note 14, at 75-119.
17. This conclusion is reached in a December 1967 report by the research team asso-
dated with the California Civil Commitment program at the California Rehabilitation
Center in Corona. Kramer, Bass & Berecochea, Civil Commitment for Addicts: The Cali-
fornia Program, in Proceedings, supra note 2, at 45-59. About one out of three addicts
in the California commitment program remained in good standing after their first release
to outpatient status. However, only one out of six has remained in good standing after
8 years.
Of those who were returned to the institution and subsequently re-released, only 25%
remained in good standing for one year. This, of course, leaves an increasing number of
multiple reddivists. The researchers conclude that the California civil commitment pro-
gram will induce periods of abstinence in some individuals, but in a far fewer number
than had been hoped for. They also point to perhaps the most important consequence
of a high degree of failure in a compulsory program:
The ultimate effect has been to produce a system into which a large number of ad-
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members will stay indefinitely,'8 claims some success, but this method
of treatment is suitable for only a tiny part of the addict population.0
Despite the spectacular results of methadone maintenance, both in
absolute terms and in comparison with alternative treatments, there
is strong opposition to its expansion as a form of treatment. One of
the arguments advanced by critics is that methadone maintenance
will create a grave social cost by leading to increased addiction-heroin
or methadone-in the general population.20 In a letter to the Yale
Law Journal, the Bureau of Narcotics raises the spectre of a general
social decline should methadone dependence be accepted by society:
The Bureau does have a vital role . . . to alert society as to the
possible pitfalls and to caution against mass acceptance of a theory
which could adversely affect our society by increased addiction.
Will there be any deterrence when potential users are assured
that there will be no ill consequences from drugs experimenta-
tion; indeed, that addicts may even receive preferential treatment?
dicts are locked, most of them shifting between approximately equal periods of in-
carceration and parole. Though a small proportion of the population are removed
from the system by "succeeding," the majority will either remain in the system until
the termination of their commitment or be extruded from the system following sus-
pension .... The value of a program like this should not be viewed solely in terms
of the number who succeed but also in terms of what happens to the majority who
do not.
Id. at 58.
As Chein has pointed out, very little thought was given "to the question of whether
psychotherapy is something that can be administered by force." CHaiN, supra note 1, at
332. Nevertheless, these programs have been heralded as the hope for the future. The
TASK FORCE RFPORT, supra note I, at 16, says: "This trend [towards developing civil com-
mitment programs] has broad public acceptance; perhaps it has even assumed the propor-
tions of a movement."
18. Synanon involves "the formation of a unique system in the community, a complete
living and working situation, the utilization of residents in the treatment or management
of their peers, the absence of direct professional staff in treatment and management .
REHABILITATING THE NARcoTIC ADDICr, supra note 14, at 203.
19. O'DONNELL & BALL, supra note 11, at 178. See Volkman & Cressy, Differential As-
sociation and the Rehabilitation of Drug Addicts, in O'DONNELL & BALL, supra note 11,
at 209-33.
Much the same must be said for Daytop Lodge, a half-way house for probationers
with a history of heroin addiction, which utilizes a method of treatment quite similar to
that of Synanon; the program is small and the available data not auspicious in terms of
the eventual integration of Daytop members into society. REHABILITATING TilE HEROIN AD-
DIrCT, supra note 14, at 239-44; Hearings, supra note 1, at 293.
20. Dr. Dole indicates that each year a tiny per cent of the drug seizures made by
New York police is methadone, suggesting that a small percentage of the existing addict
population uses methadone as the drug of primary addiction. Interview with Dr. Vincent
Dole, Feb. 7, 1969.
Although the analogy is inaccurate, the Bureau of Narcotics may be haunted by the
fact that when heroin was initially introduced it was "hailed by medical men as a non-
habit-forming substitute for opium or morphine or as a cure for drug addiction." A.
LINDESMITH, OPIATES AND ADDICTION 208 (1968).
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What will be the result of having no social stigma against addict-
proselytizers in our communities?
21
If the Bureau's fear of increased addiction stems from a prediction
that the expansion of maintenance programs would make methadone
more readily available to non-patients, that fear should be quieted by
the experience of the Dole program. Careful administration procedures
within maintenance programs can successfully minimize drug diver-
sion to potential addicts.
22
The thrust of the Bureau's rhetorical questions seems to be that
widespread use of methadone treatment will hamper the government's
efforts to deter narcotics addiction in general. The feared weakening
in deterrence would presumably arise both from a lessening of the ill
consequences of drug experimentation and from a reduction in the
social stigma which attaches to addiction. In the absence of needed
empirical data, the theoretical debate over the causes of addiction
remains unresolved, and thus it is impossible to evaluate the impact
which a lessening of ill consequences and a reduction of stigma would
have on the creation of new addicts.2a But regardless of the underlying
causes of addiction, the establishment of methadone treatment would
not lessen most of the ill consequences which are presumed to deter
potential drug users. The wider use of methadone treatment would
leave unaffected the many criminal sanctions now existing in the
general narcotics area. In addition, a methadone program promises not
legal drug highs, but a lifetime of inconvenient medical manage-
ment.24 Finally, an argument that methadone treatment is undesirable
21. Letter from Donald Miller, Chief Counsel to Bureau of Narcotics and Dangerous
Drugs, to the Yale Law Journal, January 6, 1969 [hereinafter dted as Bureau of Nar-
cotics Letter], on file at the Yale Law Journal.
22. During the outpatient phase, the patient returns to the program daily to receive
his dose under the supervision of a physician. Only after the patient has full) demon-
strated his reliability is he allowed to take out doses of medication for a number of days.
Even during this period, at least once per week "each patient is required to drink a full
dose of the medication in the clinic, and thus demonstrate that lie has maintained his
tolerance by taking medication during the intervals." 750 Criminal Addicts, supra note 2,
at 2709-10. Thus it becomes impossible for the outpatient to give his drug to someone
else without being detected quickly. The danger of drug diversion, however, is a genuine
one. As the number of methadone programs increase, care must be taken not to sacrifice
vital administrative safeguards, including carefully trained personnel. See Hearings, supra
note 1, at 832.
Nor is it likely that methadone patients would be drug proselytizers, as the Bureau's
letter seems to suggest. It is widely believed that addicts convert others to addiction not
out of any missionary zeal, but to create a market for drugs the), sell in order to get funds
to maintain their own costly drug supplies. See CH N, supra note 1, at 376.
23. See CtmEN, supra note 1, at 376-77, 380. See generally, A. Lm!orsIMtI, ArminoN &,o
OPiATrs 97-127, 157-89 (1968); O'DONNELL & BALL, supra note 11, at 62-140.
24. Furthermore, if new methadone programs continue to adopt Dole's requirement of
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because it makes heroin use less risky could be used to defeat any
attempt to find an effective treatment for heroin addiction.
The suggestion by the Bureau that the social stigma attached to
drug use would be weakened by an expansion of methadone treat-
ment is one which cannot be either confirmed or refuted by existing
data. It is extremely likely that powerful social stigma would remain
for drug use outside a treatment setting; however, even were stigma
to be reduced, the other ill consequences of addiction, described above,
would continue to exercise a very strong deterrent effect. While it does
not then seem likely that a reduction in the stigma attached to
methadone maintenance would significantly lower deterrence of
narcotics addition in general, any reduction in stigma would itself
be an enormous step toward realization of an equally crucial goal, the
rehabilitation of addicts and their reintegration into society.20
The argument most frequently made against methadone programs
is that they require maintaining patients indefinitely on an addicting
drug. The thrust of this criticism goes beyond the admitted incon-
venience to the patient of having to take his daily dosage. Drug
abstinence is viewed by many as an indispensable treatment goal for
all addicts.
Different treatment programs, of course, use different rehabilitative
methods, and have different, even conflicting, treatment goals. A doctor
who conceives of treatment only in terms of abstinence, and who runs
a treatment program geared to freeing the addict permanently from
dependence on any drug, would argue that methadone maintenance
merely substitutes one addiction for another and is not "treatment" at
all.26 But another doctor, who emphasizes social and vocational
four years of heroin use before admission, any experimentation with heroin that resulted
in addiction would condemn the heroin user to a lengthy purgatory.
An interesting footnote to the debate described in the text is the recent finding by Jaffe
that the availability of methadone maintenance as a possible method of treatment does
not inevitably destroy the motivation of addicts to achieve abstinence by participating
in one of the available abstinence-oriented treatment methods. Jaffe 1969, supra note 2, at 5.
25. Even assuming that more addicts are created through a lessening of the occasions
for fear, Chein argues that
these would be individuals who had already failed to find alternative solutions
to their problems and who had not received any effective help in doing so. It fol-
lows that the posited line of action would, for them, be adaptive; they would be seek-
ing what seemed the best available treatment for their distress. It may be that, in
thus calling attention to themselves and to their problems, they could be helped to find
more adequate solutions. But what if not? . . . . If the best that our society has to
offer them is narcosis, what moral right would we have to withhold it from them?
CHEIN, supra note 1, at 380-81.
26. See, e.g., REHABILITATING THE NARCOTIC ADDIar, supra note 14, at 283 (informal
remarks of Dr. V. Vogel), 284 (informal remarks of Dr. D. Myerson), 378 (informal remarks
of Dr. A. Bassin); N.Y. Times, Feb. 16, 1966, at 88, col. 1 (remarks by Dr. R. Baird, Direc.
tor of Haven Clinic).
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rehabilitation as a treatment goal, might well find the objective of a
program like Synanon, in which many of the ex-addicts live per-
manently in an addict community, to be abstinence without real
rehabilitation.
27
In support of the abstinence requirement, critics of maintenance
often invoke (1) past experiences with unsuccessful heroin mainten-
ance programs; (2) widely held views about the physical and social
consequences of addiction; and (3) theories about the causes of
addiction.
Controversial heroin maintenance programs that existed in the
United States from 1919 to 1923 and now operate in Britain are pointed
to by both critics and supporters of maintenance programs."-'8 The
most telling criticism of both heroin maintenance experiences is that
drugs were illicitly diverted and that heroin use spread. But two
distinctive features of methadone make it more suitable than heroin
for a maintenance program. The large drug dispensations in heroin
maintenance programs are a practical necessity. Because of heroin's
short duration of action, intense withdrawal symptoms appear within
hours after intake of the drug; addicts may need several shots a day,
and the only feasible solution is to give the addicts drugs for self-
27. Dole and Nysvander write: "Those of us who are primarily concerned with the
social productivity of our patients define success in terms of behavior--the ability of the
patients to live as normal citizens in the community-whereas other groups seek total
abstinence, even if it means confinement of the subjects to an institution." D 6- N Theories,
supra note 9, at 365.
28. For a dear example of the use of earlier experiences with heroin maintenance
programs to support a critical view of methadone maintenance treatment, see AMA Com-
mittee on Alcoholism and Drug Dependence, Management of Narcotic-Drug Depenidence
by High-Dosage Methadone HCI Technique, 201 JA.M.A. 956, 957 (1967). See also PcaK,
supra note 1, at 336.
The British system, which services Britain's approximately 500 heroin addicts, permits
individual physicians to prescribe heroin to addicts on a regular basis. For different assess.
ments of the British effort, compare E. Scuua, NA~coric ADDicriox.r i BArA.- A%D
AzmEacA (1962) and A. LImDEsmsrrH, THE ADDiCt AND THE LAw 162-88 (Vintage ed., 1065)
with Larrimore & Brill, Report to Gov. Nelson A. Rochefeller of an On-the-site Study of
the British Narcotic System, 60 N.Y.S. J. oF MED. 107-15 (January, 1960) (condensed
version). Recently there have been some reports of drug diversion and an increase in
British addiction, apparently due, in part, to casual methods of administration. Bwley,
Heroin Addiction in the United Kingdom 1954-64, 2 BmsH Ma. J. 1284, 1286 (1965);
Brill & Larrimore, Report to Gov. Nelson Rochefeller of a Second On-the-site Study of
the British Narcotic System (1965), reprinted in Hearings, supra note 1, at A-479.
Administrative shortcomings are also cited as one of the reasons for the failure of
America's hastily organized and controversial heroin clinics of 50 years ago. Whether
these clinics actually failed, and the reasons for their dosing, are much debated. A.M.A.
Council on Mental Health, Review of the Operation of Narcotics 'Clinics, Between 1919-23,
in O'DONNEEL & BALL, supra note 14, at 180-87; Ausubel, Controversial issues in the
Management of Drug Addiction: Legalization, Ambulatory Treatment and the British
System, in O'DONNEL.L & BALL, supra note 14, at 195-209. See also, Comment, Narcotics
Regulation, 62 YALE L.J. 751, 784-87 (1953). It should be noted that in neither the British
program nor the American clinic plan was drug-dispensing combined with other treatment
and rehabilitation components.
1183
The Yale Law Journal
administration. 29 Heroin maintenance programs are further compli-
cated because adaptation of the patient's body to certain of the drug's
effects leads the patient to demand increasingly large dosages to stay
comfortable. 30 Thus, attempts to stabilize the dosage levels of patients
are likely to fail.31 Methadone, however, is a horse of a different
color. Unlike heroin, methadone is long-acting; the entire daily dosage
can be given under direct observation, eliminating the opportunity
for illicit distribution.32 And methadone patients have been stabilized
at constant dosages with no difficulty.33
A second class of arguments against the maintenance aspect of
methadone programs invokes not past experience, but commonly
held beliefs about the consequences of addiction. Some critics believe
that all addiction has serious physiologically debilitating effects.
4
Others claim that maintenance on an addicting drug will make social
rehabilitation impossible because of the "well-proven personality de-
terioration and social demoralization that have invariably accompanied
addiction."3 5 The simple answer to this criticism is that Dole's research
29. See King, The Narcotics Bureau and the Harrison Act: Jailing the Healers and
the Sick, 62 YALE L.J. 736, 740 n.23 (1953).
30. See CHEIN, supra note 1, at 249-50, 360. But see Ploscowe, Some Basic Problems in
Drug Addiction and Suggestions for Research, in JOINT COMMIrEE OF TilE A.B.A. AND
THE A.M.A. ON NARCOTIC DRUGS, DRUG ADDICrIoN: CRME OR DISEASE? 42 (1961).
31. Furthermore, "[w]ith progressive escalation of narcotic requirement, any mainte-
nance program would fail to rehabilitate the patients since their energies would remain
directed toward drug-seeking. If patients continued to behave and think like addicts, the
only result of maintenance would be to shift the source of drugs from the street to the
medical clinic. This could not be an acceptable result." Lowinson, The Methadone
Maintenance Research Program, in REHABILITATING THE NARCOTIC ADDICr, supra note 14,
at 271, 278 [hereinafter cited as LowinsonJ. But Cf. CHEIN, supra note 1, at 378, and note
42 infra.
32. See note 22 supra.
33. Lowinson, supra note 31, at 278-79. See also Brill, Three Approaches to the Case.
work Treatment of Narcotics Addicts, 13 SoCIAL WORK 25, 31-32 (April, 1968).
34. There is dispute whether even heroin has any serious physiologically debilitating
effects; these effects may rather be due to "the lack of the drug and the constant pre-
occupation with obtaining it." Ploscowe, supra note 30, at 69. For example, available
evidence indicates that the addict's ability to work is undermined by not receiving Ills
customary dosage of heroin, rather than by the effects of the drug itself; that is, inefficiency
is a symptom of the withdrawal syndrome. CHEIN, supra note 1, at 558, 362. In any case,
methadone appears to eliminate whatever physiologically debilitating effects heroin might
have.
35. Ausubel, The Dole-Nyswander Treatment of Heroin Addiction, 195 JA.M.A. 949,
950 (1966). See also SENATE JUDICIARY COMM., SUBCOMM. ON IMPROVEMENTS IN TIE FEDERAL
CRIMINAL CODE, THE TREATMENT AND REHABILITATION OF NARCOTICS ADDICTS, S. Rin'. No.
1850, 84th Cong., 1st Sess. 15 (1955). These hearings were held in response to a proposal by
the New York Academy of Medicine to re-establish the heroin clinics.
The "personality deterioration" and "social demoralization" associated with heroin
addiction seem more a consequence of our legal and social policy toward drug addiction
than a consequence of opiate use itself. These policies, not to mention other social
policies that breed human misery and may have led the addict to drugs in the first
place, force the addict to lead a way of life that quite understandably may involve him
in deviant or criminal behavior, and leave him a broken person. Ploscowe, supra note 30,
at 46; A. LINDEsMITH, OPIATE ADDICTION 87-88 (1947). See generally, PACKER, supra note 1,
at 332-37; TASK FORCE REPORT, supra note 1.
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belies it.36 The source of this particular critical approach may well be
in the puritanical spirit which Etzioni finds "still sufficiently strong
in American culture so that the use of any substitute drugs . . . is
regarded as an indulgence."' 7 Any reliance on drugs, regardless of
important distinctions as to their harmfulness, is seen as weakness-
and thus the view that any form of legalized dependency is morally
offensive.3  But this view of drug dependence is not consistently
applied; the maintenance of diabetics on insulin, for example, is a
form of dependency which is accepted without moral controversy.3 0
36. See pp. 1177-78 supra. See also Lowinson, supra note 31, at 277-78; WHO ExrERT
Coisnirrrrx ON DEP-NDENcE PRODUcING DRUGS, FiFrEENm REPORT, W.H.O. Technical Rc-
port Series No. 343, at 10 (1966) (methadone maintenance has demonstrated that social
rehabilitation of subjects with a drug dependency is possible). Even relatively unfavorable
statements on methadone do not charge that methadone has any negative physical effect
on patients. The objections by the AMA Committee on Alcoholism and Drug Dependence
do not even seem to be on medical grounds. The Committee says that methadone is
addicting, but the only significance they attribute to this is that if the drug is withdrawn
the addict would experience "severe abstinence" symptoms. However, after citing the
failure of what they admit were poorly administered heroin clinics, the Committee con-
dudes without argument, that "[Currently no nation not even among the opium
producing countries, considers maintenance to be a satisfactory answer to the drug abuse
problem." AMA Committee on Alcoholism and Drug Dependence, supra note 28, at 957.
There has been no evidence of toxic effects of the drug. EvALuArION, supra note 2. at
2714. See also Blinick, Menstrual Function and Pregnancy in Narcotics Addicts Treated
with Methadone, in Proceedings, supra note 2, at 41-43 (menstrual problems and infertility
of female heroin addicts ended by methadone maintenance program).
Ausubel speculates that the large doses of methadone administered actually induce
euphoria. Ausube, supra note 85, at 949.50. That theory has little support and has been
rejected by the World Health Organization, supra note 36, and the AMA Committee onAlcoholism and Drug Dependence, supra ote 28, at 956:
The daily oral administration of large doses of methadone, a dependence-inducngmorphine-like narcotic analgesic, differs from other maintenance methods in that
the successive peaks of lation obtained by repeated intravenous or subcutaneoushypodermic injections are replaed by, a sustained an  uniform drug action with t
notable elation. The major psychologic and pharmacologic reinforcing factor, i.e., the
anticipation and realization of the drug-induced "high" 'which occurs when the drug
is injected intravenously, apparently is abolished. Elimination of the hypodermic
needie destroys another psychologic reinforcer, the so-called needle habit.Arguments similar to Ausubes are voiced by Louis Yablonsky in Stoned on Methadone,
155 Nm' pmuc, Aug. 18, 1966, at 14-16. It should be noted that shortly after the
Yablonsky article was printed, a methadone patient named John Scaza, whom Yablon.'3y
had referred to as a "mummy man," wrote the N3w Lr'unLe stating that he is
currently working as a concrete laborer and that his family "likes the normalness of me."
155 Nxwv REPUBLICo, Sept. 16, 1966, at 37-38 (1966).
87. Etzion, supra note 6, at 46. C y. IN, supra note I, at 365.66.
88. See Ausubel, supra note 85. This view was expressed by a Senate Subcommitteediscussing a proposal to reestablish heroin clinics:
The crux of the "dinic" proposal ultimately rests, not upon its practical workability
but upon the fundamentalo r issue involved. ... We behlive the thought of
permanently maintaining drug addiction with "sustaining" doses of narcotic drugs
to the addict to be utterly repugnant to the moral principles inherent in our laws
and the character of our people.
SENATE JUDICIARY C~OMM., SUBCO MMITr"EE ON IMtPROVE.MEN'TS IN TIlE FEDERAz. CRusINAL.
CODE, supra note 85, at 12-18 (emphasis added). For a brief discussion of the relation
between the addiction crackdown in the 1920's and Prohibition, see King supra note 29.
at 787.
89. In their first artide, Dole and Nyorander suggest this analogy between methadone
maintenance for heroin addicts and insulin maintenanc for diabetics. 195 J.Adg.A. 646-50
1185
The Yale Law Journal Vol. 78: 1175, 1969
The third class of objections to the maintenance aspect of metha-
done programs focuses not on the consequences of addiction but
upon its causes. "The evidence indicates that all addicts suffer from
deep-rooted major personality disorders" 40 and, so the argument runs,
maintenance on methadone cannot get to root causes of the disease.
This "psychogenic" theory of addiction-that addiction is caused by
an antecedent character defect-has come under strong attack.4"
But even if more substantial medical knowledge should eventually
prove it correct, methadone maintenance might be thought no less
valuable because (1) the program in all its aspects may actually affect
those psychological causes42 or (2) whatever its theoretical defects,
(Aug. 1965). It is arguable that the analogy fails because in the case of heroin addiction
the disease is "voluntarily" contracted and, some say, can be cured if the patient has a
sufficiently strong character. This has been vigorously debated. See, e.g., note 41 inlra.
However, the diabetes example proves a basic point, that an across the board condem-
nation of all drug dependency as immoral is foolish. See also note 25 supra.
40. CHEIN, supra note 1, at 14.
41. See D&N Theories, supra note 9. Dole and Nyswander question the psychogenic
theory and propose an alternative theory emphasizing the metabolic aspects of addiction.
They believe that the addict is biochemically defective and requires drugs much the
same way as the diabetic requires insulin. They reject the idea that all addicts are highly
disturbed individuals, preferring the belief that "addict traits" arc the consequences and
not the causes of addiction. In support of their view, they point to the fact that while
methadone patients after stabilization exhibit emotional problems related to external
situations (e.g., jobs, schools, family), these patients, whose drug hunger has been relieved,
"exhibit [no] residual psychopathology." Id. at 365. Dole and Nyswander do not believe
that the supportive assistance which their program provides explains their patients'
vocational and social success. Their conclusion is that
either the patients we admitted to treatment were quite exceptional, or else we had
been misled by the traditional theories of addiction. If, as is generally assumed, our
patients' long-standing addiction to heroin had been based on weakness of character-
either a self-indulgent quest for euphoria, or a need to escape reality-it was difficult
to understand why they so consistently accepted a program that blocked the euphoric
action of heroin and other narcotic drugs, or how they could overcome the frustrations
and anxieties of competing directly and hold responsible jobs.
Id. at 361.
42. Even if addiction is a consequence of psychological disorders, Dole and Nyswander
may simply underestimate the importance of the psychologically supportive aspects of
their program, including the therapeutic role played by their presence and enthusiastic
attention to their patients. See note 52 infra. Furthermore, by relieving the addict's con-
suming hunger for drugs, methadone dispensation is a crucial adjunct to the program's
supportive services and an effective aid to social rehabilitation. If the addict is a man
with many problems, the methadone dispensation may help to meet at least some of
them. Chein's analysis of the dynamics of the English system of handling addicts suggests
that even "mere" drug dispensation may be important for the addict's psychological
rehabilitation:
[T]here is an amazing paradox in the English system. The addict within the system is
limited to maintenance doses. But as a consequence of tolerance, he should be having
no effect other than the prevention of withdrawal symptoms. Why not, then, get
himself humanely detoxified and continue without the threat of sudden withdrawal?
Obviously, the addict who stays in the system must be getting something out of It
that has nothing to do with the psychopharmacological effects of the drug lie is
taking....
The major gain for the English addict who stays in the system must be that he has
someone who is willing to talk to him and listen to his troubles, and who proves that
he cares by giving him something, the narcotic.
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methadone maintenance may still be the most effective treatment
available from the patient's vantage point as well as from society's.
4 3
The usual danger of symptomatic treatment is that by merely
masking the causes of a disease, it allows those causes to fester and
destroy the organism. But after stabilization on methadone, the addicts
treated by Dole become increasingly healthy and equipped to deal
with the demands of everyday life. Even were maintenance on
methadone known to restrict the patient's activity more than "full"
rehabilitation or abstinence, these other forms of treatment have been
tried and have proven unsuccessful for many of the patients in Dole's
program. For these addicts the alternative to methadone maintenance
is continued heroin addiction and further misery.
44
A final objection to Dole's program is that the use of methadone is
still in the "research" stage and may not yet be considered established
"treatment." The conclusion that flows from this labeling exercise
is that methadone maintenance is proper only if programs are kept
small and are structured to answer specific questions, rather than
to provide therapy.
45
The major effect on our urban chronic opiate users ... is that it provides an answer
to emptiness. Specifically, the addict gets three things out of his involvement with
narcotics[:] . . . an identity[,] . . . a place in a subsociety where he is unequivocally
accepted as a peer, ... [and] a career.
I. Chein, Psychological, Social and Epidemiological Factors in Drug Addiction, in RE-
HABILTATING THE NARcoTic ADDIr, supra note 14, at 64-65. Earlier Chein concludes that
"heroin is a better maintainer of self-esteem than hospitalization." RztiusurrATrzsc Te
NAncoric ADDICT 27 (informal remarks).
45. It is possible, of course, that Dole and N)swander are wrong, and that in
fact their treatment masks the symptoms of the deeper disease of an addictive personality.
The usefulness of debate over this question is questionable, given our sparse knowledge
of the causes of addiction. The important questions are: "In what wvay does this allegedly
symptomatic treatment hinder the patient?" and "What better alternatives do we have
to offer?"
It should be pointed out that if methadone is not a "cure," it is reasonable to think
that its widespread use will decrease the pressure on society to commit the resources to
develop and implement "cure" programs. More importantly, to the extent that methadone
maintenance removes the ugly manifestations of drug addiction (e.g., crime), it could
decrease the pressure on society to commit resources to eradicate the human misery and
poverty that is widely associated with addiction.
44. "If the person is better off with the drug than without it, insofar as it is humanly
possible to do something for him, then he ought to have the drug. If we do not like it,
we should find better ways of helping him." Chein, supra note 42, at 69-70.
45. The Chief Counsel to the Bureau of Narcotics writes:
Some persons claim that adequate "research" has been done, and that a positive
"treatment" program may be established. Again, the Bureau has looked to the views
of the representative medical bodies, which have concluded that methadone addiction
maintenance remains a research undertaking, and that it cannot be considered as
established treatment.
In order to be considered as "treatment," it must be more than promising-it
must be proven.... The Bureau does have a vital role, even if it is only to act as a
catalyst against mass acceptance of a theory which could adversely affect our society...
Bureau of Narcotics Letter, supra note 21.
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The essence of this position must be that, given its own articulated
goals, Dole's program has not yet been sufficiently tested to be accepted
as successful by the medical community and considered as one of the
standard therapeutic procedures available to trained physicians treat-
ing addicts.46 Naturally those doctors who oppose the maintenance
concept in principle will require especially powerful data before they
become convinced of the safety and effectiveness of Dole's program,
even within its own terms; 47 while some doctors do not attack the
program directly, on the basis of its treatment goals, they take the
second-line tactic of stalling for time by proposing additional research
questions.4
Dole and his supporters do not, of course, maintain that all research
relevant to methadone maintenance has been successfully completed.
A series of further research questions recommended by the New York
State Evaluation Committee -efer explicitly to modifications in the
Now several years old, a statement on methadone by a joint committee of the American
Medical Association and the National Research Council, calls for "carefully specified and
controlled procedures . . . to evaluate adequately the various facets of the program."
The AMA-NRC statement is quoted in a later statement about methadone maintenance
by the AMA Committee on Alcoholism and Drug Dependence which called for the
"application of the most rigid research controls" to the methadone programs. The Com-
mittee says: "It is disquieting to those who would like to see this program continue at a
properly controlled research level to know that it has since been presented as if it were an
established effective treatment method that might be taught to any interested physician."
AMA Committee on Alcoholism and Drug Dependence, supra note 28, at 956. See also
Jaffe 1969, supra note 2, at 1.
46. AMA Committee on Alcoholism and Drug Dependence, supra note 28.
47. Doctors deeply hostile to the basic goal of methadone treatment may even oppose
research. Cf. World Medical Association, Declaration of Helsinki, Recommendations
Guiding Doctors in Clinical Research (1964), reprinted in AMERicAN MEDICAL ASSOCIA'rON,
DECLARATION OF HELSINKI AND AMA ETHICAL GUIDELINES FOR CLINICAL INVESTIGATION (un-
dated pamphlet available from the AMA) ("Clinical research cannot legitimately be carried
out unless the importance of the objective is in proportion to the inherent risk to the
subject.'). This opposition to methadone research is reported and criticized by Dr. Irvine
Page, past-President of the American Heart Association and past-Chairman of the AMA
Section on Experimental Medicine. Page, Further Evidence on Methadone and Criminal
Drug Addicts, 37 MOD. MED., March 10, 1969, at 64. Dr. Page sarcastically contrasts this
opposition to "the easy acceptance of such surgical feats as cardiac transplant." See also
Jaffe 1969, supra note 2, at 2.
48. Donald Miller, Chief Counsel to the Bureau of Narcotics, indicated in a telephone
conversation on April 4, 1969, that the research/treatment debate is "only concerned with
public health problems" and "avoids moralistic problems." But clearly the line between
research and established treatment could be crossed only when the basic idea of main-
tenance is itself accepted; and as Dr. F. Richards, a member of an AMA committee evaluat-
ing the methadone program, said in a telephone interview on April 2, 1969, "We're still
struggling with that, quite frankly."
The Bureau of Narcotics apparently considers the answer to the question of whether
addiction will be increased if methadone maintenance is adopted to be one of the
things that must be "proven" before methadone is to be considered "establish treat.
ment." Bureau of Narcotics Letter, supra note 21. It is difficult to see how and when
empirically "proven" answers to a question like this could be reached, at least in the
near future.
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basic Dole program, 49 and these modifications are now in the process
of being tested across the country. Both for better medical under-
standing and as a basis for important economic judgments,ro answers
to the following questions are vitally important: Will methadone
maintenance oe as useful for a different addict population, such as for
younger or less motivated addicts, or for a prison population?;5 What
are the therapeutically active components of Dole's program; for
example, could the extremely expensive in-patient phase be eliminated
without a significant decrease in the program's effectiveness?5 2 After
49. Although the Evaluation Committee explicitly calls Dole's program a "success,"
the Committee emphasizes that "these are volunteers, who are older than the average
street addict and may be more highly motivated. Consequently, generalizations of the
results of this program in this population, to the general addict population probably are
not justified. There remain a number of related research questions which need further
investigation." Evaluation, supra note 7, at 2714.
The Committee recommended expansion of the current program, and extension of
methadone treatment "(a) to other groups, using different criteria for admission such as
younger patients, or a prison population, in order to determine the applicability of this
treatment program to a broader segment of the addict population and (b) variations
in technique, including induction on an ambulatory basis." The) also recommend
continued follow-up and evaluation, and further research on the impact of each com-
ponent in the program. Id.
50. Although methadone itself may cost "pennies a day," methadone maintenance is
not a cheap form of treatment. An analysis of Dr. Dole's August 1, 1967-July 31, 1963
budget indicates that the full treatment program costs $1660 per out-patient per )ar,
the six-week in-patient phase itself costs about $2140. Bureau of the Budget of the City
of New York, Memorandum: Per Patient Costs of the Methadone Program (dated Aug.
16, 1967). See also Hearings, supra note 1, at 328, 332. An elimination of the in-patient
phase or other components of the program would, of course, cut costs. The most izable
saving, however, would come if addicts could be withdrawn from methadone after a
number of years. Costly procedures, however, may be justified by their success and by
estimates of the costs of not treating the addiction. See Hearings, supra note 1, at 335;
note 11 supra.
51. In Jaffe's Chicago methadone program, patients were taken randomly from a
waiting list of chronic narcotic users who had volunteered for treatment in the Drug
Abuse Program of the State of Illinois Department of Mental Health. Unlike Dole's
program, patients were not rejected because of legal entanglements, or previous history
of psychosis, alcoholism, or non-narcotic drug use; thus it is impossible to say of this
sample that potentially difficult patients were screened out, although, of course, the
sample contains only those addicts sufficiently motivated to volunteer. Jaffe modifies
Dole's procedure in a number of significant respects, but his results so far are impressiwe,
suggesting that methadone maintenance is an effective method of treatment for a larger
part of the addict population than Dole's sample has allowed anyone to conclude. Jaffe
1969, supra note 2. See note 52 infra.
Dole has conducted a recent small study at Riker's Island in New York to test the use-
fulness of methadone for addicts in prison. He has found that addicts in jail are
motivated to volunteer for methadone treatment, can begin the rehabilitative process
and be stabilized in a prison hospital, and will stay with the program after release. Dole,
Report to the Joint Legislative Executive Committee on Methadone Treatment at Riker's
Island (mimeographed paper dated May 15, 1968).
52. The In-patient Phase. Wieland's initial results from Philadelphia indicate that the
expensive in-patient phase is not an essential part of the treatment. Dividing 44 patients
into two groups, one beginning with an in-patient phase, the other directly with out-
patient (ambulatory) care, Wieland found no difference betveen the two groups' results.
On the basis of his findings-results were almost identical to those reported by Dole and
Nyswander-Wieland plans to treat all subsequent patients in the out-patient clinic,
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several years of treatment, is withdrawal from methadone possible
without the patient's return to heroin?
3
But Dole, supported by many other respected doctors, several of
whom have repeated his procedures," believes that his basic main-
tenance program has now been proven medically acceptable for at least
that addict population described by his own selection criteria. Research
is no longer necessary when a defined procedure, tested over a suffici-
ently long time period, has yielded enough data to permit an informed
judgment by decisionmakers as to the advisability of the program
under various circumstances. Since the risks of treatment are believed
to be negligible (e.g., no evidence at all of toxicity)ri" since possible
"unless there are significant medical or psycho-social complications which warrant hos-
pitalization." Wieland, supra note 2, at 36.
Jaffe's Chicago program is entirely ambulatory. The other distinguishing aspects of
the program are that (1) potentially difficult patients were not screened out; (2) the
dosage of methadone administered was significantly lower than that used by Dole and
Nyswander; (3) most of the patients were told that they would be withdrawn from
methadone after a few months. Seven months after this program began, 75% of the 60
patients were still in treatment, and of the group still in treatment 75% were employed,
none was using illegal drugs regularly (15% show occasional use), and there had been
one arrest. Jaffe 1969, supra note 2. Clearly, many patients do not appear to need an in-
patient phase, although for some a period of hospitalization may be needed to develop
a positive relationship between physician and patient, and to prepare the patient for Ihis
new life. See CHEIN, supra note 1, at 382. Jaffe looks to future studies to provide a basis
for deciding which patients are best suited for totally ambulatory treatment.
Personalities of Program Operators and Their Relationship with Patients. Jaffe's study
has also attempted to resolve the widely discussed question of whether "the benefits of
the use of methadone are attributable . . . to the charismatic personalities of those who
operated the programs," for example Dole and Nyswander. His limited results suggest
that this therapeutic component is not necessary for the program's success. "No single
individual or profession has exerted a dominant influence on our program. The rehabilita-
tive aspects ofYour program were directed by social workers and ex-addicts. . . . Physicians
came to the clinics only to prescribe medication and to attend to medical problems.
These physicians were intermittently rotated." Jaffe 1969, supra note 2, at 5. Wieland,
however, indicates that there is a significant difference between "the potency of methadone
alone versus the potency of methadone plus a trusting relationship." He considers a trust-
ing relationship an essential ingredient for successful treatment. Wieland, supra note 2,
at 36-37.
Urine Testing. Urine monitoring has been necessary to gather research data. Is the
presence of that monitoring itself important in keeping the addict away from the illegal
heroin market and in achieving the other successful treatment results? Is it a useful
treatment aid, merely a research evaluation component, or a "check" being used in a
moralistic way to see that the patient abides by the "rules of the game"?
53. Jaffe and Wieland indicate that they are beginning to attempt withdrawal from
methadone with some patients. Jaffe 1969, supra note 2, at 6. Wieland, supra note 2, at 38.
See note 3 supra. If the value of methadone maintenance is itself accepted, there is no
reason why open questions about ultimate withdrawal from methadone should Interfere
with expansion of the current efforts; hypotheses about withdrawal can be tested after
heroin addicts become methadone patients.
54. Wieland, supra note 2; Freedman, Fink, Sharoff & Zaks, Cyclozocaine and Methadone
in Narcotics Addiction, 202 JA.M.A. 191 (1967). See also Jaffe 1969, supra note 2, at 1.
55. See note 36 supra. Of course methadone treatment projects a lifetime of drug
maintenance. Thus, although no sign of toxicity has appeared during the first five years
of Dole's program, and there is no evidence of toxic effects from methadone's other uses,
there is always some possibility that toxic effects will begin to emerge after five, ten, or
twenty years of use.
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benefits to both the patient and society are great as weighed against
the likely effects of non-treatment, and since the likely proportion of
treatment failures is predictable and communicable to the patient,
Dole's program should now be considered a valid form of treatment.
What Dole fears is that the call for more research, research which is
not needed before responsible therapy could begin, may be used to
delay the basic changes in national drug policies which acceptance of
methadone treatment would entail. 0
When the various medical arguments against a program on Dole's
model have each been considered, the proven results of Dole's program
remain persuasive. The risks described by critics of methadone must be
evaluated in light of the known personal and social costs of current ap-
proaches to addiction. The still point in the debate over the effects,
goals, and proper limits of methadone programs is that methadone
maintenance on the Dole model provides relief significantly more effec-
tive than that provided by any available alternative program for an
important class of the addict population. Since the addict population is
heterogeneous, different treatment approaches may be suitable for dif-
ferent kinds of addicts.57 At a minimum, no sound medical reason can
be given for opposing the expansion of Dole's present program to in-
clude the 1000 properly screened heroin addicts already on waiting lists
who desperately seek his treatment in New York.
II. Problems Under Federal Law 8
Assuming that an expanded methadone maintenance program is con-
sidered to be medically and socially desirable, what would be the legal
56. The grounds for impatience with the endless calls for more research in the field
of addiction are summarized by Schur-
It is becoming increasingly questionable whether lack of adequate knowledge about
addiction provides a justification for inaction or complacency about the status quo
in the policy realm. In certain circles it has been traditional to meet all demands for
reform of drug laws with a call for "further research," and obviously no responsible
social scientist is going to oppose properly focused research efforts. Yet in the absence
of some sudden revelation identifying a crucial and hitherto unrecognized causal factor
or some major breakthrough in the development of addiction treatment techniques,
it seems foolhardy to ignore the possibilities of ameliorating at least ancillary features
of the narcotic situation through the adoption of more sensible and humane public
policies.
Schur, Book Review, 17 STAN. L. REv. 1189 (1965).
57. Freedman, Drug-Addiction: An Eclectic View 197 JA.A. 878 (1966). No treaunent
modality should be thought of in terms of its appropriateness for all addicts. As in usual
therapeutic interventions, the physician treating addicts will have available a number of
treatment procedures, and will select the procedure which he considers likely to be most
effective with the individual patients. (This, of course, assumes some agreement that the
main goal of the therapy is to make possible productive social behavior, as considered
above, some doctors subordinate this treatment goal to a goal of immediate abstinence.)
See note 24 supra.
58. This Note is limited to a discussion of the scope of federal power in present federal
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obstacles to its implementation? Both because of methadone's relative
newness as employed by Dole and because of its addictive qualities, po-
tential restrictions on its use arise under both the Federal Food, Drug,
and Cosmetics Act and the Harrison Act.
A. Under the Federal Food, Drug, and Cosmetics Act
The use of methadone for maintenance presents an unusual set of
problems under the Federal Food, Drug, and Cosmetic Act, which
establishes procedures to assure that "new drugs" will not be intro-
duced into interstate commerce until their safety and effectiveness have
been proven. 59 Before a "new drug" is marketed across state lines, the
Food and Drug Administration must approve a new drug application
(NDA);60 where there is not sufficient proof that a new drug is safe
laws. It does not consider the effect of commitments the United States made at the Hague
Opium Convention of 1912 or at subsequent international conventions on the control of
narcotic drugs. See King, An Appraisal of International, British and Selected European
Narcotic Drug Laws, Regulations and Policies, in JOINT CoMMN-rE. OF Tilt A.B.A. AND
THE A.M.A. ON NARCOTIC DRUcs, DRUG ADnICrON: CRIME OR DISEAsE? 121-25. (1961).
Nor does this Note concern itself with state laws regulating the use of narcotic drugs
by physicians. The Uniform Narcotic Drug Act is followed in many states, and, like the
Harrison Act, appears to allow doctors wide latitude in treating addicts or other patients
with addicting drugs. Section 7 of the Uniform Act allows the physician "in good faith
and in the course of his professional practice only" to prescribe, administer, or dispense
narcotic drugs to addicts. Thus, an interpretation of the Harrison Act will also suggest an
approach for physicians under state law. States, of course, may pass laws stricter than the
Uniform Narcotic Drug Act, delineating specific behavior which is proper for a doctor
and that which is not. California, for example, has set extremely strict standards for
doctors treating addicts. Maximum daily doses to be given during a fixed number of days
to achieve withdrawal (the only permissible treatment goal) are written into the statute.
CALIF. HEALTH & SAFETY CODE §§ 11390-11396 (West 1964). See especially Elder v. Bd. of
Med. Examiners, 50 Cal. Rptr. 304 (1966) (physician's license revoked for dispensing
methedrine as a substitute for the addict's narcotic, a violation of California statute).
Jaffe indicates the uncertainty he felt as to whether Illinois law would allow even research
with methadone maintenance. Jaffe 1969, supra note 2, at 2. The Illinois statute explicitly
allowed a doctor to administer narcotic drugs only to patients "suffering from a disease
. ..other than for addiction." ILL. REV. STAT. ch. 38, § 22-11 (1964). However, at Jalfe's
urging, Illinois became the first state to provide specially in its laws for "research and
experimental programs involving the administration of methadone," provided approval
is received from the State Department of Mental Health. ILL. REv. STAT. ch. 38, § 22-10.1
(Supp. 1969). Cf. N.Y. MENTAL HYGIENE LAW § 204(3) (McKinney Supp. 1968).
59. 21 U.S.C.A. § 301 et al. (Supp. 1968).
60. 21 U.S.C.A. § 335(a) (Supp. 1968). The manufacturer may market without NDA
approval any drug he believes to be "generally recognized as safe and effective." The
government may then "seize and condemn" such drugs if it can establish by a preponder-
ance of the evidence that the drug is "not generally recognized as safe and ctective."
See, e.g., United States v. Articles of Drug Labeled "Quick-O-ver", 274 F. Supp. 443
(D. Md. 1967); United States v. Article of Drug Labeled " ynn 30", 268 F. Supp. 245
(EP. Mo. 1967). Cf. United States v. Wood, 226 F.2d 924 (4th Cir. 1955). If medical
opinions differ, some courts conclude as a matter of law that the drug in question Is not
geeall reonzd assfe ad efetv.AM Inc.v Gardner 275 F. up 410 41
(S.D.N.Y. 1967) ("For such difference [of medical opinion] indicates precisely the lack of
general recognition of the safety of plaintiff's products which brings them within the
statutory definition of new drugs."). See also Merritt Corp. v. Folsom, 165 F. Supp. 418(D.D.C. 1958); United States v. 354 Bulk Cartons Trim Reducing-Aid Cigarettes, 178 F.
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and effective, an alternative procedure permits the drug's manufacturer
or sponsor to claim an investigational new drug exemption (IND) and
send the drug into interstate commerce for testing only."1
The first question concerning methadone maintenance under the
FDgcC Act is whether the "new drug" provisions are applicable at all.
Methadone is not a "new" drug in the customary sense; the use of
methadone as a painkiller is well established, and its use in some aspects
of the treatment of heroin addiction-during withdrawal, or for a
brief period prior to withdrawal on a maintenance basis-is widely
accepted.62 However, an accepted drug like methadone would require
new drug approval if it were marketed in interstate commerce for a
new use "not generally recognized as safe and effective."6a
The manufacturers of methadone have remained aloof from the
controversy, making no labeling changes or new claims for the drug,
and they have not been required to file a new drug application. It is
possible, of course, that the FDA might require methadone manufac-
turers to change their labeling of the drug to encompass its use in
maintenance programs, and also require that a new drug application
be filed for that use.0 4 However, the FDA's inaction in the face of six
years of widely publicized methadone use in maintenance programs
suggests that manufacturers will not now be required to follow "new
drug" procedures; had the use of methadone in maintenance programs
required such procedures, the FDA would seem to have been obligated
to act long ago.65
Supp. 847 (D.NJ. 1959). Other courts, however, have put a heavier evidentiary burden
on the government, holding that the existence of some disagrenent among the expz-rt
witnesses does not necessarily mean that the safety and efficacy of the drug for that pur-
pose is not generally recognized among qualified experts. United States v. Article of Drug
Labelled "Quick-O-ver", 274 F. Supp. 443, 448-49 (D. Md. 1967).
61. 21 U.S.C.A. § 355(i) (Supp. 1968).
62. AMA Council on Mental Health and the National Academy of Sciencrs--National
Research Council Committee on Problems of Drug Dependence, Narcotics and Medical
Practice, 202 J.A.M.A. 209, 210-11 (1967) [hereinafter cited as AMA-NRC (1967)].
63. 21 U.S.C.A. 32 1(p) (Supp. 1968). According to the regulations:
The newness of a drug may arise by reason (among other reasons) of .. . (5) The
newness of a dosage, or method of duration of administration or application, or other
condition of use prescribed, recommended, or suggested in the labeling of such drug,
even though such drug when used in other dosage, or other method or duration of
administration or application, or different condition is not a new drug.
21 C.F.R. § 130.1(h)(5) (1968). See also AMP Inc. v. Gardner, 275 F. Supp. 410 (S.D.N.Y.
1967).
64. The regulations provide that a manufacturer must change the labeling on the
drug if he receives notice "that a drug ... introduced into interstate commerce by him
is to be used for conditions, purposes, or uses other than the ones for which he offers it."
21 C.F.R. § 1.106(o) (1967).
65. The FDA may recognize the special problems in this situation of proceeding against
the manufacturers of methadone. Methadone is an inexpensive drug produced by several
manufacturers (the patent has expired), who continue to send the drug through interstate
commerce for its customary uses. To require these manufacturers to change the labeling
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Since a new drug application may eventually be filed by a manu-
facturer or sponsor for methadone, a brief discussion of the applicable
standards for approval is in order. The standards for new drug ap-
proval incorporated in the 1962 amendments to the FD&C Act suggest
that approval for methadone in a maintenance use should be granted. 6
To be approved, the new drug must be "safe for use under the
conditions prescribed, ' ' 67 and there must be "substantial evidence that
the drug will have the effects it purports or is represented to have
under the conditions of use prescribed."68 A "preponderant evidence"
test was rejected by the draftsmen of the Act in favor of the "sub-
stantial evidence" test, because consensus or even majority rule was
felt to be unsound within the medical profession." Since the major
dispute over the "effectiveness" of methadone maintenance centers
around disapproval of the program's treatment goals rather than its
efficacy in achieving those goals, this controversy should not stand in
the way of new drug approval. It is not the function of the FDA to
pass judgment on treatment goals, but only to ensure that a drug be
effective in achieving the purposes claimed for it, and to require that
any limitations upon those purposes be clearly stated in the drug's
labeling and advertising.
Since the criteria permit and even direct approval where medical
opinion is split, FDA approval of methadone in its new use would be
at this stage would force them to undergo expensive and lengthy procedures necessary to
gain "new drug" approval. This might have the effect of forcing the manufacturers to
cease methadone production entirely. See Cavers, The Legal Control of the Clinical In.
vestigation of Drugs: Some Political, Economic, and Social Questions, 98 DAEDALUS 430-3,1
(Spring 1969).
66. Under FDA regulations, the procedures that must be followed in order to win
approval are extraordinarily lengthy. And in practice, the FDA has applied the standards
strngently. See Cavers, supra note 65, at 430-34; Remarks of Karl Beyer, M.D., at 1964
FDA-FLI Conference, 20 Food Drug Cosm. L.J. 75, 75-79 (1965); Comment, The Drug
Amendments of 1962, 38 N.Y.U. L. Rev. 1082, 1092 n.71 (1963).
67. 21 U.S.C.A. § 355(d) (Supp. 1968). Safety, of course, does not mean absolute absence
of risk. Rather, the requirement is for adequate warning to the doctor of a drug's inherent
dangers. Furthermore, no medical treatment, especially with drugs, is without risks. Cf.
RESTATEMENT (SECOND) OF TORTS § 402A, comment k. See note 128 infra.
68. [T]he term "substantial evidence" means evidence consisting of adequate and
well controlled investigations, including clinical investigations, by experts qualified
by scientific training and experience to evaluate the effectiveness of the drug involved,
on the basis of which it could fairly and responsibly be concluded by such experts
that the drug will have the effect it purports or is represented to have under the
conditions of use prescribed, recommended, or suggested in the labeling or proposed
labeling thereof.
21 U.S.C.A. § 355(d) (Supp. 1968).
69. The committee recognizes that in the difficult area of drug testing and evalua-
tion there will frequently, if not usually, be a difference of responsible opinion. The
committee feels that the existence of such a difference should not result in disapproval
of a claim of effectiveness if it is supported by substantial evidence as defined in the
manner set forth below ....
Committee on the Judiciary of the Senate, S. Rep. No. 1744, pt. 2 (1962).
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justified; further labeling changes could be made at a later time when
more data has been collected regarding methadone's effectiveness
with a wider addict population or in a different treatment setting.
The labeling change would leave no doubt about the manufacturer's
right to ship methadone interstate to be used in m-intenance pro-
grams, and would thus be a crucial step in the general acceptance of
methadone maintenance.
If, however, the FDA should be unvilling to classify the use of
methadone for maintenance purposes as safe and effective, maintenance
programs could still continue under the investigational new drug
exemption.70 That exemption is granted according to strict regulations,
and sponsors and investigators are held to rigorous research standards.-'
The National Institute of Mental Health, which, although it is sub-
sidizing five methadone maintenance programs, has no direct control
over the drug's supply, has filed an IND for these investigational
programs.72 Presumably, since the statute says "any person" may file
a new drug application,73 the NIMH could file an NDA making an
enlarged claim for methadone's use; and since NIMH-supported in-
vestigators are testing modifications in Dole's program, the NIMH
data could be used to get new drug approval of methadone for a wide
range of uses.
B. Under the Harrison Act
According to the Bureau of Narcotics, any doctor who uses meth-
adone maintenance as treatment for heroin addicts violates federal
law.74 The basis for the Bureau's position is the Harrison Act-a
federal regulatory measure passed in 1914-which requires the regis-
tration of narcotics dispensers,75 imposes an excise tax on narcotic
70. 21 US.C.A. § 355(i) (Supp. 1968).
71. For the general duties of -an investigator who has a sponsor covered by the Act.
see 21 US.C. § 355(i); 21 C.F.R. § 130.3(c) (196S); 21 C.F.R. § 130.37 (1968). Cf. Turkel v.
FDA, 334 F.2d 844 (6th Cir. 1964).
72. An investigator who gets his supply of an established drug on the local market
and puts it to a new use is not required to file an IND. 21 U-5.C.A. § 331(d) (Supp. 1965).
See Cavers, supra note 65, at 440-43.
Whether or not a doctor is directly covered by the FDA regulations, his failure to
follow the prescribing information on the package insert could expose him to liability
for departing from an accepted norm if there is resulting harm, although the litigation
here is minimal. Id.; Sanzari v. Rosenfeld, 34 N.J. 128, 167 A.2d 625 (1961); cf. Toole v.
Richardson-Merrill, Inc., 60 Cal. Rptr. 398, 409 (1967).
73. 21 U.S.C.A. § 355(b) (Supp. 1968). See Rutherford v. AM, 379 F.2d 6-1 (7th Cir.
1967).
74. Bureau of Narcotics Letter, supra note 21.
75. 26 US.C.A. §§ 4721-22 (1967). Registrants, which include manufacturers, doctors,
pharmacists, etc., are required to pay a small occupational tax and to keep records. The
purpose of these provisions is dearly to keep the drug traflic observable.
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drugs (to be evidenced by stamps affixed to the package containing
the drugs),7 and limits the sale and distribution of narcotics to recipi-
ents who use a written order form provided by the Treasury Depart-
ment.7
7
When first passed, the Act did not appear to interfere with the
medical treatment of addicts. The obvious targets for prosecution were
doctor-pushers and prescription peddlers.78  Reputable physicians,
"treating addicts as they saw fit,"7 9 were prescribing and dispensing
narcotics, and explicit statutory exemptions appeared to protect
them in their good faith professional activities.8 0 The section re-
quiring use of a written order form, for example, contained a specific
exemption for "the dispensing or distribution of any narcotic drugs to
a patient . . . in the course of [a physician's] professional practice
only."8' And in a similar vein, a 1919 amendment to the Act, making
illegal the dispensing of narcotics not in their original stamped pack-
ages, exempted doctors "where said drugs are dispensed or admin-
istered to the patient for legitimate medical purposes."8' 2 Nevertheless,
the phrases "legitimate medical purposes" and "in the course of his
professional practice only" were not defined, and these apparent qual-
ifications on the physician's exemptions have become a source of legal
controversy.8
3
76. 26 U.S.C.A. § 4701 (1967). A 1919 amendment made it unlawful to sell or dispense
drugs not in their original stamp package. 26 U.S.C.A. § 4704 (1967).
77. 26 U.S.C.A. § 4705 (1967). Because methadone is a narcotic as defined in 26 U.S.c.
§ 4731 (1967), its use is governed by the Harrison Act. U.S. Treasury Dept., Bureau of
Narcotics, TRAFFIc IN OPIUM AND OTHER DANGEROUS DRUGS, REPORT FOR THE YEAR ENDED
DEc. 31, 1965 (1966). Methadone (trade name Amidone Hydrochloride) has been within
the act since July 31, 1947, when Treasury Proclamation No. 2738 was issued. 12 Fed.
Reg. 5269. Note that the Bureau of Narcotics was recently transferred from the Treasury
Department to the Justice Department. 33 Fed. Reg. 5611 (eff. Apr. 8, 1968).
78. "[Addicts] could and did get relief from any reputable medical practitioner, and
there is not the slightest suggestion that Congress intended to change this-beyond cutting
off the disreputable 'pushers' who were thriving outside the medical profession and along
its peripheries." King, supra note 29, at 737.
79. Ploscowe, supra note 30, at 69.
80. That the statutory exemption left physicians their wide professional discretion
was a widely held belief at the time. See, e.g., Simmons v. United States, 300 F. 321, 322
(6th Cir. 1924).
81. 26 U.S.C.A. § 4705(c)(1) (1967).
82. 26 U.S.C.A. § 4704(b)(2) (1967). No person, including a doctor, may use an order
form to obtain narcotic drugs "for any purpose other than the use . . . in the legitimate
practice of his profession." 26 U.S.C.A. § 4705(g) (1967). Persons not registered under one
of the relevant provisions of the Act may possess narcotic drugs when they have been"prescribed in good faith" by a physician. 26 U.S.C.A. § 4724(c) (1967). For other similar
exemptions, see 26 U.S.C.A. § 4704(b)(1), § 4705(c), and § 4724(b)(5-6) (1967).
83. The development of the "British system" (see note 27 supra) from Dangerous Drug
Laws which are quite similar to the Harrison Act, provides a fascinating contrast to the
development of our own country's policy, with its emphasis on criminal sanctions and
intimidation of doctors. See A. LINDFSMrrH, THE ADDi=r AND THE LAW, 167-70 (1965).
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According to a widely distributed Bureau regulation:
A prescription, in order to be effective in legalizing the possession
of unstamped narcotic drugs and eliminating the necessity for the
use of order forms, must be issued for legitimate medical pur-
poses .... An order purporting to be a prescription issued to an
addict or habitual user of narcotics, not in the course of pro-
fessional treatment but for the purpose of providing the user with
narcotics sufficient to keep him comfortable by maintaining
his customary use, is not a prescription within the meaning and
intent of the act; and ... the person issuing it, may be charged
with violation of the law.84
In addition to its own rigid standard, the Bureau in recent years has
looked to the joint statements of the American Medical Association
(AMA) and National Research Council (NRC) for guidance about
appropriate medical standards in the treatment of addicts.8 5 The
AMA-NRC Committee, however, has also concluded that in general
"continued administration of narcotic drugs solely for the maintenance
of dependence is not bona fide attempt at treatment, nor is it ethical
medical practice.""0 Thus by reference either to its own regulation or
to the AMA-NRC statement, the Bureau concludes that methadone
maintenance treatment programs are illegal; however, since the
AMA-NRC statement makes provision for research, the Bureau has
allowed limited methadone programs to go forward for investigational
purposes.
87
Analysis of case law and administrative history indicates that the
Bureau's interpretation of the Harrison Act is improper, and that its
current approach to methadone maintenance should be modified to
protect the many physicians who believe that methadone maintenance
is a sound form of treatment.
The Good Faith Medical Purposes Test. The language of the
84. 26 C.F.R. § 151.592 (1967). This provision appears at the beginning of a pamphlet
which was sent by the Bureau of Narcotics to practicing ph)sicians in March, 1966, in an
attempt to "generate interest in treating and curing narcotic addiction" and to apprise
physicians of "the policy of the U.S. government" as regards the "ethical" treatment of
drug addicts. PAMP.Er No. 56; supra note 14, at 1-2. The pamphlet also contains, at
8-21, a reprint of a 1963 statement by the AMA Council on Mental Health and National
Academy of Sciences-National Research Council, Narcotics and Medical Practice [herein.
after cited as AMA-NRC (1963)].
85. See Bureau of Narcotics Letter, supra note 21.
86. AfA-NRC (1967), supra note 63, at 139 (emphasis in original). This statement is a
condensation of a revision of the original AMA-NRC statement of 1963, supra note 84.
87. AMA-NRG (1967), supra note 63, at 140. The Bureau regulation makes no pro-
vision for research.
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present Bureau regulation 8 is derived from Webb v. United States,0
one of the first cases to interpret the Harrison Act's exemption for
physicians. In Webb, "professional treatment" was restricted to treat-
ment which attempted to cure the addict's habit 0 Supreme Court cases
decided during the years immediately following Webb accepted and
even added to the requirement Webb had engrafted onto the Harrison
Act's exemption.' Adopting the Webb position, the Bureau regulation
states that narcotic drugs cannot be prescribed "to keep [an addict]
comfortable by maintaining his customary use," and seems to allow
88. Quoted at p. 1197 supra.
89. 249 U.S. 96 (1919) (doctor who peddled over 4,000 drug prescriptions indiscrimi-
nately at fifty cents apiece, sometimes using fictitious names on them, convicted of violat-
ing the Harrison Act).
90. The following question was certified to the court in Webb:
If a practicing and registered physician issues an order for morphine to an habitual
user thereof, the order not being issued by him in the course of professional treat-
ment in the attempted cure of the habit, but being issued for the purpose of pro-
viding the user with morphine sufficient to keep him comfortable by maintaining
his customary use, is such an order a physician's prescription under [tile provision
which exempts physicians from the application of the Harrison Act]?
Id. at 99. The Supreme Court, four Justices dissenting, answered that "to call such an
order for the use of morphine a physician's prescription would be so plain a perversion
of meaning that no discussion of the subject is required." Id. at 99-100.
By structuring their sentences so as to assume that "professional treatment" does not
include "providing the user with narcotics sufficient to eep him comfortable by main-
taining his customary use," both the question certified in Webb and the Bureau regulation
attempt to settle the controversial question by begging it.
91. In Jin Fuey Moy v. United States, 254 U.S. 189 (1920), the Court held that a doctor
could not legitimately prescribe drugs "for the mere purpose, as the jury might find, of
enabling such persons to continue the use of the drug," or "to cater to the appetite or
satisfy the craving of one addicted to the use of the drug." Id. at 193-94. The case clearly
involved abuse, the doctor having peddled prescriptions to all comers, many not patients.
In United States v. Behrman, 258 U.S. 280 (1922), a most confusing case, the Court
affirmed the conviction of a doctor who had written a prescription for narcotics large
enough to provide 3000 injections. Although the facts indicated abuse, the case had the
effect of taking away from physicians the defense of good faith. In what Rufus King calls
a "trick indictment," the government had not alleged that the prescriptions were contrary
to approved and proper treatment, but in effect alleged that the drugs were given In a
good faith attempt to cure the addict. King, supra note 29, at 741. Justices Hohnes,
Brandeis, and McReynolds dissented, Holmes saying that the indictment alleged that the
drugs were administered in good faith in the course of the doctor's practice, and that
this brought Behrman within the statute's exemption. He refused to read the statute as
"tacitly making such acts, however foolish, crimes, . . . if the Court deems the doctor's
faith in his patient manifestly unwarranted." Id. at 290.
Although the effect of the case was to remove the defense of good faith, the Court itself
focused on the large dispensation of drugs for self-administration, which the Court said
"could only result in the gratification of a diseased appetite for these pernicious drugs or
result in an unlawful parting with them to others in violation of the act as heretofore
interpreted in this Court within the principles laid down in the Webb and fin Fuey Moy
Cases" Id. at 289. The Court hedged away, however, from saying that all dispensations of
drugs for self-administration were prohibited for all kinds of patients as a matter of law:
"It may be admitted that to prescribe a single dose, or even a number of doses, may not
bring a physician within the penalties of the act . . . . Undoubtedly doses may be varied
to suit different cases as determined by the judgment of a physician." Id. at 288-89.
Rufus King sums up the impact of these cases by saying that "the Narcotics Division
succeeded in creating a very large criminal class for itself to police (i.e., the whole addict-
doctor-patient-addict-peddler community), instead of the very small one that Congress
had intended (the smuggler and the peddler)." King, supra note 29, at 738.
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only the administration of diminishing doses while the addict is under-
going withdrawal. Frequent prosecution and conviction of doctors dis-
couraged most members of the profession from the treatment of
addicts.92
However, within 7 years after Webb, in Linder v. United States3
and Boyd v. United States,94 the Supreme Court had significantly
clarified the rights of physicians under federal law to dispense and
prescribe narcotic drugs. These more recent decisions have been ig-
nored by the Narcotics Bureau in official pronouncements to doctors.
5
The indictment in Linder questioned neither the doctor's good
faith medical purpose nor his adherence to proper standards of medi-
cal practice.96 In effect, it simply asserted that Dr. Linder had dis-
pensed one morphine tablet and three cocaine tablets to an addict-
informer for the sole purpose of "relieving conditions incident to
addiction and keeping [the patient] comfortable,"9 17 on the assumption
that this action was sufficient to constitute an offense under the Harri-
son Act. In reversing Linder's conviction and writing for a unanimous
Court, Justice McReynolds repudiated the Webb test, pointing out
quite correctly that the Harrison Act says nothing about addicts, and
does not purport to prescribe methods for their medical treatment."-
Whether the doctor was engaged in "bona fide medical practice" was
to be determined by looking at "evidence and attending circum-
stances,"99 and thus not simply by referring to a single method of
92. A. LINDE-IM7, THE ADDICr AND = LA'W 6-7 (1965).
93. 268 U.S. 5 (1925).
94. 271 U.S. 104 (1926).
95. See, e.g., PAMPHLEr No. 56, supra note 14.
96. 268 U.S. 5, 16-17 (1924). Dr. Linder's indictment was almost identical to that in
United States v. Behrman, 258 U.S. 280 (1922), supra note 91, except for the quantity of
drugs involved.
97. 268 U.S. at 17. Dr. Linder maintained "that the facts stated [were] not sufficient
to constitute an offense." Id. at 16. These facts included:
[Petitioner knew that the patient] was addicted to habitual use of these drugs and
did not require administration of either because of any disease other than such
addiction, and [petitioner] did not dispense them for the treatment of any other
disease or condition; they were not administered by him or by any nurse or other
person acting under his direction, nor were they consumed or intended for consump-
tion in his presence; the amount was more than sufficient to satisfy the recipient's
craving if wholly consumed at one time; petitioner put the drugs into her possession
expecting that she would administer them to herself in divided doses over a period
of time; they were in the form in which addicts usually consume them to satisfy
their cravings; the recipient was in no way prevented or restrained from disposing
of them.
Id. at 16.
98. Id. at 18. Throughout the opinion, Justice McReynolds expressed his conviction
that limitations must be placed on the power of the federal government to regulate the
medical profession by means of a revenue measure.
99. Id. at 18. The opinion distinguishes and clarifies all cases, usually with a state-
ment to the effect that the "quoted language must be confined to cieumstances like those
presented by the cause." Id. at 20.
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treatment, whether approved by the Bureau of Narcotics or anyone else.
Using this test, the Court said that it could not possibly conclude that
Dr. Linder "acted improperly or unwisely or for other than a treat-
ment purpose."'100 A fair reading of Linder, then, is that a doctor who
dispenses drugs for a good faith medical purpose has not violated the
Act.10
When taken in conjunction with Boyd v. United States,0 2 which was
decided the following year and is the last Supreme Court pronounce-
ment in the area, the Linder test for the legality of a physician's acts
becomes clearer: if the doctor dispenses or prescribes the drug "in
good faith 'for the purpose of curing disease or relieving suffering,' he
should be acquitted."' 0 3 The Boyd court distinguishes between a
prescription of drugs in which the doctor is "treating [confirmed
addicts] for addiction or endeavoring to relieve them from suffering
incident to it" (legal), and a prescription which "could only have
been issued to enable the recipients to indulge their acquired longing
for the drug and its effects" (illegal). 04 Is the defendant trying to heal
or merely to peddle? To be subject to the Harrison Act's criminal
liability the doctor must be acting with no good faith treatment pur-
pose.
Linder and Boyd clearly abandon the Webb prohibition against the
distribution of addicting drugs to persons dependent on them. A
doctor acting in good faith in the course of his professional practice
may treat addicts as he sees fit and may, in his discretion, administer
or prescribe drugs to relieve their suffering or to keep them comfor-
table; no treatment goal or method, including drug maintenance, is
proscribed as a matter of law. Despite this clear holding, the Bureau of
100. Id. at 18.
101. The case may also fairly be read to suggest a dual test for qualifying for the
Harrison Act exemption: acting for good faith medical purposes and acting in accordance
with fair medical standards. Although language about good faith and purpose per.
vades the opinion, there are two references to action in accordance with "medical stan-
dards." Id. at 17, 22. Obviously, the two tests are related. See p. 1201 infra. But the
thrust of the opinion-especially the concerns the court shows in distinguishing the
earlier cases-seems to be a purpose test: had the doctor acted to treat, or had he
merely "conspired to sell" drugs? Id. at 20. Medical standards provide a useful aid to
the court in judging the doctor's purpose, but the court must look at "attending cir-
cumstances." Id. at 18. The Linder court's references to medical standards suggest only
that if the doctor had acted for a good faith medical purpose and in accordance with
medical standards, he could not be convicted. Since the indictment did not allege that
Dr. Linder departed from either standard, the Court in its main task of sweeping away
the earlier cases did not have to sort out its test as carefully as it later did in Boyd. See
p. 1201 infra.
102. 271 U.S. 104 (1926).
103. Id. at 106.
104. Id. (emphasis added).
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Narcotics regulation described above,105 based on language in Webb
which Linder and Boyd repudiate, has never itself been appropriately
modified.108
In distinguishing between a treatment purpose and, for example,
a conspiracy to sell narcotic drugs under the guise of a prescription,
courts will naturally look to such factors as individualization of treat-
ment and the care with which large quantities of drugs are dispensed.10 7
They will also look to "medical standards," since a departure from a
procedure followed by all other reputable doctors strongly suggests
the absence of a treatment purpose. But recourse to standards is no
more than an evidentiary aid to the crucial determination for decision
-whether the doctor acted for good faith medical purposes. Thus in
Boyd, where several doses of heroin had been prescribed for self-
administration, the doling out of abnormally large prescriptions-
with the attendant risk either that the addict would consume all the
drugs at once in a thrillseeking or dangerous way, or that he would
dispose of the excess through illegal sales-was the basis for a presump-
tion; the size of the prescriptions suggested to the court that the
doctor was aiding or acquiescing in a plan to divert the drugs illegally,
or else that he cared so little about how the drugs were used as to make
the label "good faith" treatment clearly inappropriate. The Supreme
Court upheld the doctor's conviction, pointing out that the amounts
distributed "were grossly excessive and unreasonable according to
any fair medical standard,"'' 08 and that no special reason or occasion
was shown to justify the excess.
105. Quoted at p. 1197 supra.
106. PAnm=r No. 56, supra note 14. Neither Linder nor Boyd is mentioned once in
this pamphlet, which is widely distributed to doctors. The Bureau of Narcotics regulation
(p. 1197), although it holds physicians to a single standard of practice (an attempt at
withdrawal) and refuses to acknowledge other therapeutic goals as "professional treat-
ment," sets out as its major premise a test of purpose: "A prescription in order to be
effective in legalizing the possession of unstamped narcotics and eliminating the necessity
for the use of order forms, must be issued for legitimate medical purposes." 26 C.F.R.
151.392 (1967).
26 C.F.R. § 151.411 (1967), not reprinted in PAMiPHLET No. 56, suggests the statute's
more flexible approach where the drugs are dispensed directly to the patient, although
the restrictive gloss on "professional treatment" found in 26 C.F.R. § 151.392 (1967) is
probably to be read into the analogous phrases in 26 C.F.R. § M.AI. The purpose of
26 C.F._. § 151.411 is apparently only to tell physicians that they may in certain situations
dispense drugs as well as prescribe them. 26 C.F.R. § 151.411 (1967) reads: "Prescriptions
unnecessary. Practitioners may dispense narcotic drugs to bona fide patients pursuant to
the legitimate practice of their professions without prescriptions or order forms." Al-
though the cases discussed above show a concern for the amount of drugs under the
addict's control, cases like Linder and Boyd suggest that the same analysis is required both
where the doctor directly dispenses drugs and where he allows the addict to get drugs
by means of a prescription.
107. Linder v. United States, 268 U.S. 5, 20 (1925).
108. Boyd v. United States, 271 U.S. 104, 106 (1926) (emphasis added).
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On the authority of the case law, current methadone programs
would appear to be immune from legal attack under the Harrison Act.
All indications point to the conclusion that Dole and the other doctors
committed to methadone maintenance are dispensing methadone "in
good faith 'for the purpose of curing disease or relieving suffering.' "101
The drugs dispensed are in controlled dosages, and the entire admin-
istration process is carefully monitored. In contrast to the operations
of Dr. Boyd, adequate safeguards exist during all stages of Dr. Dole's
treatment program to protect against the potential problems created
when multiple dosages are dispensed for self-administration.1 0 A good
faith medical purpose is also indicated by the supplementing of drug
dispensation with counselling and other supportive techniques as
needed to aid the addict in social and vocational rehabilitation.'
Reference to Medical Standards. Although the determination of
good faith medical purpose must be recognized as the crucial element
in the adjudication of a physician's claimed exemption under the
Harrison Act, reference to objective standards of medical practice will
continue to be important. Such reference is necessary both as an aid
to the courts, because the subjective determination of good faith
medical purpose is so difficult, and because doctors might otherwise be
discouraged from treating addicts for fear that their purposes would be
misunderstood by law enforcement officials and courts."
2
109. Id.
110. See note 22, supra.
111. In discussing Dole and Nyswander's initial research, the World Health Orga-
nization uses language similar to that of the cases:
The Committee is of tie opinion that insofar as maintenance on methadone is not
carried out simply for the gratification of the individual but is used as an adjunct to
rigorous efforts toward social .rehabilitation, the employment of this procedure under
very carefully controlled conditions will be of considerable scientific interest.
WHO EXPERT CoMsMrrrE ON DEPENDENCE PRODUCING DRUGS, supra note 36, at 9.
This purpose test would exempt from the criminal provisions of the Harrison Act any
doctor who acts with a good faith medical purpose (and any patient who possesses drugs"prescribed in good faith" by a physician, 26 U.S.C.A. § 4724(c) (1967)). Departure from
medical standards may subject the doctor to professional sanctions, or, in the event of
injury to the patient, to a possible malpractice suit. But cf. notes 119 and 125 infra.
However there should be no danger of criminal liability. As Justice Holmes said, dissent-
ing in United States v. Behrman, 258 U.S. 280, 290 (1922), "[S]uch acts, however foolish,
[are not] crimes."
112. The fear many doctors express of becoming involved with treating addicts at all
is in large part caused by the incredible confusion and contradiction in circuit court cases
dealing with the dispensation of drugs to addicts. These circuit courts have experienced
great difficulty in attempting to reconcile the irreconcilable language in all the Supreme
Court's opinions interpreting the Harrison Act. It is often difficult to determine what test
these courts are using: a purpose test, a medical standards test, or some variation or com-
bination of the two.
Despite statements by most courts to the effect that the doctor's good faith is a question
of fact for the jury, some cases seem to return to Webb's broad language:
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But the particular form of reference to practice advocated by the
Bureau of Narcotics is both medically unwise and legally incorrect.
The Bureau's position is that a doctor who fails to comply with the
single standard of legitimate medical practice laid dowm by a joint
committee of the American Medical Association and the National
Research Council forfeits his professional exemption under the
When a licensed physician abuses his professional function by selling or giving away
prescriptions for drugs to known addicts, he automatically forfeits the privileges
extended to him by § 2554(c)(1) [§ 4705(c)(1) of the statute.
Lindenfeld v. United States, 142 F.2d 829, 831 (2nd Cir.), cert. denied. 323 US. 761
(1944). See United States v. Abdallah, 149 F.2d 219 (2nd Cir. 1945). See also Mauk v.
United States, 88 F.2d 557 (9th Cir.) cert. denied, 302 U.S. 684 (1937); Nelms v.
United States, 22 F.2d 79 (9th Cir. 1927). Any administration to an addict not suffering
from a disease other than addiction which requires the drug for treatment is said to be
"for the purpose of gratifying the craving for the drug" and not a "legitimate medical
purpose." Ratigan v. United States, 88 F.2d 919, 922 (9th Cir.) cert. denied, 301 U.S.
705 (1937). Similarly, a doctor's honest belief that the drugs dispensed assisted a police
chief-patient in holding his job or making him comfortable "does not establish good faith
nor alter criteria of standard medical practice." McBride v. United States, 225 F.2d 249.
253 (5th Cir. 1955), cert. dismissed as improvidently granted, 350 U.S. 934 (1956).
Some cases attempt to make a distinction between a physician and a seller of narcotics-
suggesting a good faith medical purpose test, but strongly implying that all dispensations
of addicting drugs to addicts are "sales." Nigro v. United States, 117 F.2d 624 (8th Cir.
1941); United States v. Ratigan, 7 F. Supp. 491 (W.D. N.D. 1934).
Other courts indicate more clearly that they are using a good faith medical purpose
test. See, e.g., United States v. Anthony, 15 F. Supp. 553 (S.D. Cal., 1936) (a district court
opinion, but perhaps the sanest interpretation of the Harrison Act); Boehm v. United
States, 21 F.2d 283, 285 (8th Cir. 1927); Needleman v. United States, 261 F.2d 802 (5th
Cir.), cert. denied, 362 U.S. 600 (1958) (a good faith test, but there had been evidence of
a bad faith sale); United States v. Brandenberg, 155 F.2d 110, 111 (3d Cir. 1946); DuVall v.
United States, 82 F.2d 382, 386 (9th Cir.) cert. denied, 298 U.S. 667 (1936). In Teter
v. United States, 12 F.2d 224 (7th Cir.) cert. denied, 273 U.S 706 (1926), the use
of a purpose test rather than a medical standards test worked to the detriment of the
defendant. Two doctors testified that "in the treatment of addicts it was not improper
to give them doses such as appear to have been given to the complaining witnes.' Not-
withstanding this, the court said: "[W]e are satisfied that under all the circumstances it
was for the jury to say whether or not these sales of drugs to the complaining witness
were in good faith, or were solely for the purpose of pandering to the abit of a drug
addict, and selling the drug." Id. at 225-26.
Some courts apparently use a good faith purpose test only to determine whether it was
reasonable for the defendant doctor to believe that the addict would not resell the drugs.
Bush v. United States, 16 F.2d 709, 710 (5th Cir. 1927). See also Hawkins v. United States,
90 F.2d 551, 553-55 (5th Cir.), cert. denied 302 U.S. 733 (1937) (court also indicating
that it was following the Bureau regulation and would not allow any dispensation to
addicts solely to treat their addiction).
Strader v. United States, 72 F.2d 589 (10th Cir. 1934), presents the most confusing set
of tests. The court distinguishes (as the indictment in Linder did not) between providing
drugs to keep an addict "comfortable by maintaining his customary use," and providing
drugs "to relieve a condition incident to addiction." Id. at 592. This is an obvious attempt
to reconcile Linder with the Bureau regulation, and is complete sophistry. (See
A. LINDESmIItI, THE ADDICr Arm THE LAW 13 (1965): "A doctor who provides an addict
with drugs to relieve withdrawral distress necessarily also keeps him comfortable by
maintaining customary use.) Apparently building on this distinction, the Strader court
continues that the physician must act "in good faith and in accord ith fair medical
standards,' but that "evidence" of medical standards is crucial "because of its bearing
upon the intent and purpose" of the doctor. If the doctor's conduct conformed to those
standards, it would indicate good faith; but if he deviates from the standards, it suggests
commercial purposes. Id. at 592. Strader's conviction was reversed partly becamuse the trial
court, holding at certain methods of treatment were not permitted as a matter of law,
had refused to allow appropriate expert testimony.
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Harrison Act.113 The gist of the joint AMA-NRC report, considered by
the Bureau as "the authoritative definition of legitimate medical prac-
tice," 1 4 is that "the continual administration of drugs for maintenance
113. Federal law provides the framework within which the medical profession
can authoritatively determine what the role of the physician will be in the treatment
of addicts and in determining alternative approaches to the addiction problem ...
Congress has imposed a responsibility upon law enforcement agencies to ascertain
whether certain practices by a physician are bona fide, and the courts have said that
physicians have no immunity from prosecution outside the scope of professional
treatment. ... [qin fulfilling the responsibilities imposed by the legislators and the
courts, the enforcement agencies have looked to the representative medical and scienti-
fie groups for policy guidance. Specifically, we have relied on the pronouncements of
the American Medical Association, and more recently the joint statements of AMA
and the National Research Council.
Bureau of Narcotics Letter, supra note 21.
Although the AMA had played a significant role in the development of Bureau of
Narcotics policy, that relationship has not been formalized until recently. See generally,
AMA-NRC (1963), supra note 84, at 9; for a discussion of the AMA's role in the hasty
closing of the narcotic clinics in this country in the 1920's, see AMA Council on Mental
Health, Review of the Operation of Narcotic "Clinics" Between 1919 and 1923, in
O'DONNELL AND BALL, supra note 11, at 180-87.
Because of inconsistent court rulings and widespread harassment of doctors, many con-
fused and fearful doctors withdrew from the treatment of addicts. In 1961 a widely
distributed report by the Joint Committee of the ABA and AMA on Narcotic Drugs
pointed out the difficulties and recommended that (1) the determination of standards of
good faith and limits of proper medical practice should not "be left to the conflicting
opinions of so-called experts, who may have differing views on how to treat narcotic
addiction" or to "twelve laymen on a jury" making "an ex post facto judgment;" (2)
"the AMA itself should determine the standards of good faith and the limits of proper
medical practice in the treatment of addicts." Ploscowe, supra note 30, at 82. The next
year the Ad Hoc Panel Report to the 1962 White House Conference on Narcotics made
similar recommendations. PROC=E iNGs: WHITE HOUSE CONFERENCE ON NARCOTC & DRUO
ABUSE 271 (1962). In 1963, the President's Advisory Commission on Narcotics and Drug
Abuse recommended that steps be taken to reflect the principle that the medical pro-
fession should determine what is the legitimate medical treatment of addicts and legitimate
medical use of narcotic drugs. PRESIDENT'S ADvisoRY CoitWSSION ON NARCOTICS AND DRuo
ABUSE, RE'ORT 57 (1963). Towards that end, the Commission requested the AMA Council
of Mental Health and the National Academy of Sciences-National Research Council to
prepare a joint statement as to what in their opinion constituted the legitimate medical
treatment of the narcotic addict. The statement (AMA-NRC (1963), supra note 84) was
printed in the Commission's final report. Id. at 83-95.
In that statement the AMA-NRC called for the establishment of "a medical body on a
national level to maintain a current 'code' of ethical medical practice with relation to
narcotics and narcotic addiction...." AMA-NRC (1963), supra note 84, at 16. In 1965,
the AMA-NRC "notified [the Bureau of Narcotics] that a joint committee of members
from AMA and NRC had been formed to act as an informal advisory body to the Bureau
of Narcotics on certain problems relating to narcotics and narcotics addiction .... " Letter
from Walter Wolman, Director, AMA Dept. of Mental Health, to Henry Giordano,
Commissioner of Narcotics (on file at Yale Ltw Journal). That body continues to function,
and in 1967 it released a revision of its 1963 statement, AMA-NRC (1967), supra note 63.
114. In 1967, the Presidential Commission on Law Enforcement and Administration of
Justice (The Crime Commission) summed up the status of the AMA-NRC statement:
The Bureau of Narcotics accepts it as the authoritative definition of legitimate medical
practice against which all medical practice is to be measured.... The Commission has
no doubt that the AMA-NRC 1963 statement was an accurate expression of the con-
sensus of medical opinion about treatment. . . . Whatever the situation may have
been before 1963, there is now no reason for any confusion or apprehension on the
part of physicians about their legal right to treat addicts-patients in most circum-
stances that are likely to arise.
TASK FORCE REPORT, supra note 1, at 19. It indicates however, that a "minority, composed
of reputable men within the medical profession . . . do not consider [the AMA-NRC
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of addiction is not a bona fide attempt at cure, nor is it ethical medical
treatment .... The maintenance of stable dose levels is generally in-
adequate and medically unsound." 1' Ironically, reliance on the views
of a medical group-an approach recommended by the President's
Advisory Commission on Narcotics and Drug Abuse and others as a
means by which to return the addict problem to the medical profession
and to encourage doctors who had been intimidated by fear of Harri-
son Act prosecution to begin treating addicts'1-has become instead
the means by which a number of respectable doctors have been either
deterred from treating addicts at all, or harrassed in their efforts to
statement] authoritative or complete. At least some of these men do not regard withdrawal
of the addict from drugs as the first, perhaps not even the ultimate, treatment objective."
Id.
In spite of the Bureau's apparent deference to the AMA-NRC, the letter to the Journal
indicates that the Bureau intends to influence AMA-NRC decision-making quite actively:
The Bureau does have a vital role, even if it is only to act as a catalyst to alert
society as to the possible pitfalls and to caution against mass acceptance of a theory
which could adversely affect our society by increased addiction. It is true that the line
of demarcation between legitimate research, treatment, and flagrant abuse is a very
cloudy one. It is neither a signal nor enviable position for this Bureau to assess
medical opinion. However, until we are told by our laws that physicians can do no
wrong; until the consenses [sic] of medical opinion indicates that medical maintenance
of addicts is professional treatment and therefore lawful, the Bureau cannot assume
laissez-faire attitude.
Bureau of Narcotics Letter, supra note 21. The Chief Counsel for the Bureau, Donald
Miller, indicated this even more emphatically during a telephone conversation. Discussing
possible AMA-NRC approval of methadone maintenance as a legitimate and established
form of treatment, Miller said that "the federal government has a very definite responsi-
bility to slow this thing down. We have to make certain the wool isn't pulled over the
eyes of the medical profession. The federal government has to hold the line since drug
maintenance may be a mistake." Miller indicated that while the Bureau has not played
an active role with the AMIA-NRC cor..mittee, the Bureau would "very definitely" play a
"very, very active" role in the future. Telephone interview with Donald Miller, Chief
Counsel to the Bureau of Narcotics, April 4, 1969.
115. AMA-NRC (1963), supra note 84, at 11, 14. Prolonged administration of narcotics
is allowed, however, in a "few unusual circumstances" for patients suffering incurable
and painful (but not necessarily fatal) diseases, patients in terminal conditions, and aged
and sick addicts for whom withdrawal is dangerous to life.
The insistence by the joint committee that only treatment programs geared to ultimate
withdrawal are medically sound and ethical medical practice is ironic in light of the
section of the statement discussing the traditional forms of "medical management of drug
dependent person" (i.e., withdrawal programs). Acknowledging that "once established,
drug dependence of morphine-type . . . has the characteristics of a chronic relapsing
disease," the statement articulates a multi-criteria test for success in the treatment of
addicts:
Withdrawal is the least complex part of treatment; indeed it is periodically accom-
plished by some persons without medical assistance. Repeated relapses occur commonly
and success or failure should not be measured only by the single criterion of relapse.
The length of drug free periods, changes in inter-personal relationships, and the
progress in social adjustment and in the patient's physical condition also should be
considered. The total course of this disorder can be influenced by adequate treatment.
AMA-NRC (1967), supra note 63, at 158 (emphasis added). It is of course precisely in terms
of these additional criteria that the methadone maintenance programs are successful,
indeed far more successful than the ordinary heroin withdrawal programs which do not
generally succeed in achieving abstinence anyway.
116. See note 113 supra.
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apply a treatment approach not popular with a majority of their
profession. 117
To take the position of the Bureau that advocates of methadone
maintenance must wait "until the consenses [sic] of medical opinion
indicates that medical maintenance of addicts is professional treat-
ment, ' 118 is to adopt a concept of government unsuited to a profession
in which sharp division over appropriate forms of treatment is the
norm. It is generally recognized that a multi-standard approach, per-
mitting a wide range of individual variation, is necessary to prevent
stultification in the profession. In civil malpractice suits, for example,
a physician is protected as long as he follows a "course of treatment
advocated by a considerable number of his professional brethren in
good standing in the community;""19 at least this much professional
discretion should be allowed under a criminal statute which cuts into
medical practice obliquely and requires no showing of actual harm to
the patient.12
0
117. In an interview on Feb. 7, 1969, Dr. Dole discussed the difficulties his program has
had with Bureau investigators. Both Jaffe and Wieland mention in their articles the anxiety
caused by the legal uncertainty of their programs. Jaffe 1969, supra note 2, at 2; Wieland,
supra note 2, at 33.
In theory, an AMA-NRC statement could be written to reflect the full range of respect-
able medical opinion-majority school, minority school, and beliefs less widely approved
but still held by respectable authority. A doctor would then both know before lie acted
that he was safe from criminal prosecution, and be free to act according to his best
professional judgment in selecting among various treatment approaches. The AMA-NRC
statement as written simply fails to reflect that full range of responsible opinion.
In practice, the hope that "impartial" panels will either resolve medical disagreements
or reflect all shades of respectable opinion may be naive. Cf. Lambert, Impartial Medical
Testimony 20 N.A.C.C.A. L.J. 25, 29 (1957) ("If a partisan to one or other school of thought
is on the so-called impartial panel, he brings his opinions with him; the wine must taste
of its own grapes.'); B. Diamond, The Fallacy of the Impartial Expert, 3 Ascit. Cum.
Psycir. 221 (1959).
118. Bureau of Narcotics Letter, supra note 21 (emphasis added).
119. McHugh v. Audet, 72 F. Supp. 394 (D.C. Penn., 1917). See, e.g., Geraty v. Kaufman,
115 Conn. 563, 162 A. 33 (1932); Sim v. Weeks, 7 Cal. App. 2d 28, 45 P.2d 350 (1935);
Force v. Gregory, 63 Conn. 167, 27 A. 1116 (1893) (not for the jury to judge the comparative
worth of different schools of treatment); Schumacher v. Murray Hospital, 58 Mont. 447,
193 P. 397 (1920); McPeak v. Vanderbilt University Hospital, 33 Tenn. App. 76, 229 S.W.2d
150 (1950); Note, The Battle of the Experts: A New Approach to an Old Problem in
Medical Testimony, 44 Nm. L.R. 539, 548 (1965). See also Scarano v. Schnoor, 158 Cal,
App. 2d 612, 323 P.2d 178 (1958); Gielskie v. State, 10 App. Div. 2d 471, 171 N.E.2d 691
(1960) (doctor who followed procedure accepted by respectable medical authority did not
have to follow the method "generally recognized as far superior," especially since all
methods involved some risks). In a recent case, Toth v. Community Hospital at Glen
Cove, 22 N.Y.2d 255, 263, 239 N.E.2d 368, 373, 292 N.Y.S.2d 440 (1968), Judge Keating
suggests that if in the exercise of his best judgment the doctor diverges from the general
medical procedure, he cannot be held liable for resulting harm, at least where his proce-
dures have "some reputable support in the profession." See also Stammer v. Bd. of Re-
gents, 262 App. Div. 372, 29 N.Y.S.2d 38 (1941), afl'd, 287 N.Y. 359, 39 N.E.2d 913 (19,12),
discussed in note 125 infra.
120. At least one lower court judge took this approach towards medical standards in a
criminal trial for violation of the Harrison Act:
If reputable physicians honestly hold to two opinions, some justifying the administra-
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And the single standard test is as legally unsound as it is medically
unwise. Since a study of the case law has shown that purpose is the
crucial test for exemption, the legal theory of the Bureau must be that
failure to comply with the single AMA-NRC standard creates an
irrebuttable presumption of a lack of good faith medical purpose. For
a court to indulge in such a presumption would be to return to the
discredited Webb approach of proscribing certain methods of treat-
ment as a matter of law.
In addition to its general statement on the medical unsoundness of
drug maintenance, the AMA-NRC has also issued a special statement
on the methadone maintenance programs. Asked by the Narctoics
Bureau for advice as to wether the Dole program was "treatment" or
"research," the AMA-NRC responded that it was "a pilot research proj-
ect to study a relatively new treatment approach," labeled it "promis-
ing," but called for further evaluation.' The Bureau has used this
description in a conclusory way. It permits methadone maintenance
when it is a "research undertaking," but will not allow a widespread
therapeutically-oriented program. -2 Thus the Bureau has recently
made a series of "inspections" of methadone programs to determine
whether they are being run "within the limits of ethical medical
practice as applied to research," by which the Bureau apparently
means kept small and devoted to information-gathering rather than
to the treatment of patients.y
don of morphine in the manner and in the quantities shown to have been administered
by Dr. Anthony to the subjects named in the indictment, and others are honestly
opposed to such opinions, and if the defendant held honestly to the opinion shown
to be that of one group of reputable medical practitioners, and in the best of good
faith acted accordingly, he would not be guilty.
United States v. Anthony, 15 F. Supp. 553, 559 (S.D. Calif. 1936).
It should be pointed out that in 1924 the AMA House of Delegates issued a famous
policy statement condemning as improper any method of addict treatment which gave
the patient drugs for self-administration. AMA-NRC (1963), supra note 84, at 9. This view
was dearly not determinative of the issues arising in Harrison Act litigation. Under v.
United States, 268 U.S. 5 (1925) (physician may prescribe drugs for addict's self-administra-
tion).
121. This special statement is reproduced in AMA Committee on Alcoholism and Drug
Dependence, supra note 28, at 956. See note 45 supra. See generally pp. 1187-91 supra.
122. See note 45 supra.
123. In its letter to the Yale Law Journal, supra note 21, at 2-3, the Bureau described
its "inspections" this way:
The Bureau has refrained from any action which might restrict research and there
are now several research methadone addiction maintenance programs being conducted
in the United States. Since such activities must be carried out within the limits of
ethical medical practice as applied to research, and since it is still the job of this
Bureau to make certain that narcotic drugs are not being diverted into illicit channels,
it has been necessary for us to make inspections, seek appropriate explanations, and,
when necessary, to recommend corrective action. Sonic ph)sicians strongly protest a
police officer making inquiries into professional practice, and our activities have been
interpreted as disruptive. However most researchers recognize the nedico-legal prob-
lems involved, and we have had a good working relationship with then.
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Whichever label the Bureau uses, a doctor should always be safe
from Harrison Act liability when he is following treatment procedures
approved by other respected doctors; once a doctor has cleared his pro-
cedure with an appropriate advisory body,124 he should have no need
to negotiate with the Bureau of Narcotics under threat of legal attack,
regardless of whether he calls his program research or treatment. At a
time when the medical and legal professions are just beginning to give
extended consideration to the complex ethical problems of medical
research, 25 it is inappropriate for the Bureau of Narcotics to threaten
criminal prosecution for activities not carried out "within the limits of
ethical medical practice as applied to research," both because those
"limits" have not been defined in any detail by the profession and be-
cause, for historical reasons, the mere presence of Bureau investiga-
tors intimidates doctors and arouses their resentment. 120
124. For example, the use of decentralized, hospital committees to review the judgment
of experimenters is now required for any grant under the jurisdiction of the National
Institute of Health, which sponsors five methadone research programs. For a general
discussion of the role of these institutional review committees and their possible future
role in the regulation of medical research on humans, see Calabresi, Reflections on Medical
Experimentation in Humans, 98 DAEDALUS, Spring 1969, at 399-403; Curran, Governmental
Relation of the Use of Human Subjects in Medical Research: The Approach of Two
Federal Agencies, 98 DAEDALUS, Spring 1969, at 542, 576-88; Freund, Introduction to the
Issue "Ethical Aspects of Experimentation with Human Subjects," 98 DAEDALUS, Spring
1969, at x-xi; Jaffe, Law as a System of Control, 98 DAEDALUS, Spring 1969, at 406, 409-10,
419-20; Katz, The Education of the Physician-Investigator, 98 DAEDALUS, Spring 1969,
at 494-97.
125. It is widely agreed that the use of an "experimental" procedure is proper when
"there is no established procedure for handling the medical problem confronting the
physician" or when "the application of established and approved treatments and pro-
cedures has failed to bring about an improvement of the patient's condition." SnA~RTEL &
PLANT, THE LAW OF MEDICAL PRACTICE 122-23 (1959). The Declaration of Helsinki, perhaps
the most important codification of ethical guidelines for medical experimentation, makes
an important distinction between therapeutic experimentation and non-therapeutic experi-
mentation, and of the former says: "In the treatment of the sick person, the doctor must
be free to use a new therapeutic measure, if in his judgment it offers hope of saving life,
reestablishing health, or alleviating suffering." World Medical Association, supra note 47.
In one of the few litigated cases in this area, Stammer v. Bd. of Regents, 262 App. Div.
372, 29 N.Y.S.2d 38 (1941), aff'd, 287 N.Y. 359, 39 N.E.2d 913 (1942), the court overturned
the suspension of a physician's license to practice for having used in the treatment of
cancer a "secret formula" that was unknown and without support in the medical profession.
The court pointed to the doctor's skill, the patient's full knowledge and consent, the failure
of other known methods, and the need to encourage initiative and originality in the
medical profession. For the importance of the patient's informed consent to liability-free
experimentation, see SHARTEL & PLANT, THE LAW OF MEDICAL PRACTICE 38-40, and cases
cited therein; Stason, The Role of Law in Medical Progress, 32 LAW AND CONTEMP. PROa.
563 (1967); Blumgart, The Medical Framework for Viewing the Problem of Human
Experimentation, 98 DAEDALUS, Spring 1969, at 248, 255-62; Freund, Legal Frameworks for
Human Experimentation, 98 DAEDALUS, Spring 1969, at 314; Katz, supra note 124; Jaffe,
supra note 124, at 420-22.
In the treatment of addiction, there is dearly no generally accepted, successful method
of treatment. In this situation, keeping in mind that in the care ofthe patient the doctor
should always use his professional judgment and weigh risk of treatment against risk of no
treatment, the justification for the use of an "experimental" procedure for therapeutic
purposes is great.
126. See generally 98 DAEDALUS, Spring 1969 (Symposium on Ethical Aspects of Experi-
mentation with Human Subjects); 32 LAW AND CONTEMP. PROB. 561-750 (Autumn 1967)
(Symposium on Medical Progress and the Law).
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Furthermore, for the Bureau to say that methadone "research" but
not methadone "treatment" will be allowed is to engage in a meaning-
less labeling game; it is by no means clear that sensible distinctions be-
tween therapeutic research and treatment can be made. 127 Criteria such
as safety, effectiveness, and purpose do not effectively distinguish thera-
peutic research from treatment,128 nor does calling a procedure "re-
search," as opposed to "treatment," itself determine the scale on which
that procedure should be used or the safeguards necessary for the
patient.2 9
The best distinction between therapeutic research and treatment is
one based on "knowableness"; for example, enough data probably
exists about Dole's basic program to permit a fully informed judgment
on the advisability of its expanded use, whereas variants of his pro-
gram which eliminate the in-patient phase or accept a larger part of
the addict population cannot be evaluated as completely until they
have been more thoroughly tested and become more "knowable."'
' 0
But once this distinction has been recognized, the most pressing issue
regarding methadone maintenance remains: is it wise or proper to
use a treatment effort on a large scale when both the risks and effec-
tiveness of the proposed treatment are not fully known?
An expansion of methadone treatment under conditions where risk
127. See Katz, supra note 124. See also Freund, supra note 124, at viii-ix.
128. The notion that a distinction can be drawn on the basis of safety breaks down
when one considers that some accepted "treatments," such as cardiac cathetcrization and
digitalis in the diagnosis and care of heart disease, are every bit as risky as so-called
"research." Indeed, medical treatment is always risky in that even the safest of drugs,
such as aspirin, may, in particular instances, produce dangerous side effects.
Reference to effectiveness also proves unsatisfactory as a basis for distinguishing between
research and treatment. Obviously, a method of treatment may prove ineffective on a
patient, regardless of drug labeling or favorable indications before treatment. Some pro-
cedures accepted as treatment are applied without much clear indication of likely effective-
ness; e.g., heroin addiction treatment methods and programs other than methadone
maintenance.
The idea that in research the purpose is to acquire medical knowledge, whilc in treat-
ment it is to care for the patient, makes little sense since much research takes place in
the context of therapy, and since most therapeutic interventions today are considered
experimental. See articles cited in note 127 supra.
In addition, it is not correct to say that for procedures called treatment there is a
general agreement about appropriateness, or an understanding of the reasons for effective.
ness (e.g., shock treatments).
129. The notion that research may not appropriately be run on a large scale falters
abruptly when one recalls the widescale testing of the poliomyelitis %accine.
As Dr. Jay Katz asks, "[1f consent becomes an important requisite in clinical research
combined with therapeutic care, should it be obtained in therapeutic interventions? Does
it make any difference whether the same medical procedure is carried out in the context
of a research study or not?" Katz, supra note 124, at 497 n.7. A procedure labeled research,
of course, usually contains evaluation features.
180. Of course we could have the knowledge that a medical procedure yields 90%
success (and thus feel justified in its large-scale use) but still not have a way of determining
the risk or prognosis for success for any individual patient,
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and effectiveness are not well known raises a range of questions need-
ing the most serious consideration by decisionmakers from the legal,
medical, and lay communities, questions which are currently over-
shadowed by the debate defined by the Bureau of Narcotics. 131
The most difficult questions concern procedures affecting the volun-
tariness of the addict's involvement in treatment. What sort of consent
should be required of "volunteers"?132 Since many addicts may not be
motivated to seek treatment on their own (this lack of motivation may
be part of the disease), what attempts, if any, to recruit addicts for
methodone treatment would be proper? What procedures, if any,
should be used for enlisting addicts in prison? When addicts are
civilly committed, what is the content of their "right to treatment"-
for example, when several methods for treating addicts are available,
what role should the addict play in the selection of a treatment pro-
cedure?133 Given a risk of harm or a possibility of failure, in what
situations, if any, may a treatment procedure be compelled, or made a
condition of parole? 3
4
These questions are especially important because a social program
promising a reduction in crime may be seized upon by those whose
zeal for order can lead to all too casual disregard of the dignity and
rights of the individual. Thus it is appropriate to question whose
interests planners are considering when they talk of benefits and costs
131. The distortion brought about by the Bureau's policy that only methadone
"research" programs are allowed is shown by the recent announcement in New York City
that a five-year methadone "research" program was being developed (with help of the
Vera Institute of Justice) to treat 5000 addicts. New York's purposes would seem clear:
with an enormous addict population, a soaring crime rate, and no other proven effective
treatment program available, the political leadership has seized on methadone mainte-
nance hoping that it will yield significant results. While this program will be answering
significant questions and while there are enough variables to justify the program's size
(presumably a program could always be made to look like research, especially if expensive
evaluation components were built in), calling the program research is either deceptive or
meaningless. The city, after all, will be creating an enormous population dependent on
methadone, and could not very easily call its program off at the end of five years. The
label "research" is applied by the City not because the word can be given significant
content, but because it might bring the program within the Bureau of Narcotics' "research"
authorization. Worst of all, the Bureau's approach focuses attention on a word, and diverts
attention away from what should be a highly visible consideration of the real issues,
which include weighing the risks and benefits to the patient and society of a large program.
132. The role of consent in medical experimentation with humans is discussed in the
articles cited in note 125 supra.
133. For an interesting discussion of the range of problems likely to arise In tile
development of the right to treatment following Rouse v. Cameron, 373 F.2d 451 (D.C.
Cir. 1966), see Katz, The Right to Treatment (initial draft of a paper to be published in
the UNvEasrry OF CHICAGO LAW REvIEw).
134. Cf. People ex rel. Blunt v. Narcotic Addiction Control Comm'n, N.Y.L.J., July 23,
1968, p. 11, col. 5F; Note, Civil Commitment of Narcotics Addicts, 76 YALE L.J. 1160 (1967).
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of a proposed policy; compassion for the addict is not the same thing
as pity for ourselves. As a program comes under the control of those
whose concerns are primarily to reduce crime, the program may take
on the main characteristics of a non-therapeutic research effort, where
pursuing a goal of benefit to society may conflict with the best interests
of the patient/subject. In such a situation, the need for safeguards is
most acute, for the individual's autonomy is most vulnerable.
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